Counteracting poisoning with chemical warfare nerve agents

1Holmstedt B. Structure-activity relationships of the organophosphorus anticholinesterase agents. In: Koelle GB, editor. Cholinesterases and anticholinesterase agents. Berlin: Springer-Verlag; 1963. p. 428–85. Holmstedt B Structure-activity relationships of the organophosphorus anticholinesterase agents In Koelle GB editor Cholinesterases and anticholinesterase agents Berlin Springer-Verlag 1963 p 428 8510.1007/978-3-642-99875-1_9Search in Google Scholar

2Chambers HW. Organophosphorus compounds: an overview. In: Chambers JE, Levi PE, editors. Organophosphates: chemistry, fate, and effects. San Diego: Academic Press; 1992. p. 3-17. Chambers HW Organophosphorus compounds: an overview In Chambers JE Levi PE editors Organophosphates: chemistry, fate, and effects San Diego Academic Press 1992 p 3 1710.1016/B978-0-08-091726-9.50005-7Search in Google Scholar

3Eddleston M, Buckley NA, Eyer P, Dawson AH. Management of acute organophosphorus pesticide poisoning. Lancet 2008;371:597–607. doi: 10.1016/S0140-6736(07)61202-1 Eddleston M Buckley NA Eyer P Dawson AH Management of acute organophosphorus pesticide poisoning Lancet 2008371597 607 doi 10.1016/S0140-6736(07)61202-1Open DOISearch in Google Scholar

4Kaur HG, Garg H. Pesticides: environmental impacts and management strategies. In: Larramendy ML, Soloneski S, editors. Pesticides - toxic aspects. London: IntechOpen; 2014. p. 187–229. doi: 10.5772/57399 Kaur HG Garg H Pesticides: environmental impacts and management strategies In Larramendy ML Soloneski S editors Pesticides - toxic aspects London IntechOpen 2014 p 187 229 doi 10.5772/57399Open DOISearch in Google Scholar

5Dolgin E. Syrian gas attack reinforces need for better anti-sarin drugs. Nat Med 2013;19:1194–5. doi: 10.1038/nm1013-1194 Dolgin E Syrian gas attack reinforces need for better anti-sarin drugs Nat Med 2013191194 5 doi 10.1038/nm1013-119424100968Open DOISearch in Google Scholar

6Stone R. U.K. attack puts nerve agent in the spotlight. Science 2018;359:1314–5. doi: 10.1126/science.359.6382.1314 Stone R. U.K attack puts nerve agent in the spotlight Science 20183591314 5 doi 10.1126/science.359.6382.131429567684Open DOISearch in Google Scholar

7Bakry NM, el-Rashidy AH, Eldefrawi AT, Eldefrawi ME. Direct actions of organophosphate anticholinesterases on nicotinic and muscarinic acetylcholine receptors. J Biochem Toxicol 1988;3:235–59. doi: 10.1002/jbt.2570030404 Bakry NM el-Rashidy AH Eldefrawi AT Eldefrawi ME Direct actions of organophosphate anticholinesterases on nicotinic and muscarinic acetylcholine receptors J Biochem Toxicol 19883235 59 doi 10.1002/jbt.25700304043236334Open DOISearch in Google Scholar

8Wiener SW, Hoffman RS. Nerve agents: a comprehensive review. J Intensive Care Med 2004;19:22–37. doi: 10.1177/0885066603258659 Wiener SW Hoffman RS Nerve agents: a comprehensive review J Intensive Care Med 20041922 37 doi 10.1177/088506660325865915035752Open DOISearch in Google Scholar

9Costa LG. Toxicology of pesticides: a brief history. In: Costa LG, Galli CL, Murphy SD, editors. Toxicology of pesticides: experimental, clinical, and regulatory perspectives, NATO ASI Series. Vol. 13. Berlin-Heidelberg: Springer; 1987. p. 1–10. Costa LG Toxicology of pesticides: a brief history In Costa LG Galli CL Murphy SD editors Toxicology of pesticides: experimental, clinical, and regulatory perspectives, NATO ASI Series. Vol. 13 Berlin-Heidelberg Springer 1987 p 1 1010.1007/978-3-642-70898-5Search in Google Scholar

10Tucker JB. War of Nerves: Chemical Warfare from World War I to Al-Qaeda. New York: Anchor; 2007. Tucker JB War of Nerves: Chemical Warfare from World War I to Al-Qaeda New York Anchor 2007Search in Google Scholar

11Delfino RT, Ribeiro TS, Figueroa-Villar JD. Organophosphorus compounds as chemical warfare agents: a review. J Braz Chem Soc 2009;20:407–28. doi: 10.1590/S0103-50532009000300003 Delfino RT Ribeiro TS Figueroa-Villar JD Organophosphorus compounds as chemical warfare agents: a review J Braz Chem Soc 200920407 28 doi 10.1590/S0103-50532009000300003Open DOISearch in Google Scholar

12Sidell FR. Nerve agents. In: Sidell FR, Takafuji ET, Franz DR, editors. Medical aspects of chemical and biological warfare. Textbook of military medicine. Washington (DC): Office of the Surgeon General, Department of the Army USA; 1997. p. 129–79. Sidell FR Nerve agents In Sidell FR Takafuji ET Franz DR editors Medical aspects of chemical and biological warfare. Textbook of military medicine Washington (DC) Office of the Surgeon General, Department of the Army USA 1997 p 129 7910.21236/ADA398241Search in Google Scholar

13Hoenig SL. Nerve agents. In: Compendium of chemical warfare agents. New York (NY): Springer; 2007. p. 77–128. doi: 10.1007/978-0-387-69260-9_5 Hoenig SL Nerve agents In Compendium of chemical warfare agents New York (NY) Springer 2007 p 77 128 doi 10.1007/978-0-387-69260-9_5Open DOISearch in Google Scholar

14Pitschmann V. Overall view of chemical and biochemical weapons. Toxins (Basel) 2014;6:1761–84. doi: 10.3390/toxins6061761 Pitschmann V Overall view of chemical and biochemical weapons Toxins (Basel) 201461761 84 doi 10.3390/toxins6061761Open DOISearch in Google Scholar

15Vásárhelyi G, Földi L. History of Russia’s chemical weapons. AARMS 2007;6:135–46. Vásárhelyi G Földi L History of Russia’s chemical weapons AARMS 20076135 46Search in Google Scholar

16Carlsen L. After Salisbury nerve agents revised. Mol Inform 2019;38(8–9):e1800106. doi: 10.1002/minf.201800106 Carlsen L After Salisbury nerve agents revised Mol Inform 2019388–9e1800106 doi 10.1002/minf.201800106Open DOISearch in Google Scholar

17Pita R, Domingo J. The use of chemical weapons in the Syrian conflict. Toxics 2014;2:391–402. doi: 10.3390/toxics2030391 Pita R Domingo J The use of chemical weapons in the Syrian conflict Toxics 20142391 402 doi 10.3390/toxics2030391Open DOISearch in Google Scholar

18Balali-Mood M, Saber H. Recent advances in the treatment of organophosphorous poisonings. Iran J Med Sci 2012;37:74–91. PMCID: PMC3470074 Balali-Mood M Saber H Recent advances in the treatment of organophosphorous poisonings Iran J Med Sci 20123774 91 PMCID: PMC3470074Search in Google Scholar

19Timperley C, Forman J, Aas P, Abdollahi M, Benachour D, Al-Amri A, Baulig A, Becker-Arnold R, Borrett V, Carino FA, Curty C, Gonzalez D, Geist M, Kane W, Kovarik Z, Martínez-Alvarez R, Mikulak R, Mourao N, Neffe S, Izzati F. Advice from the Scientific Advisory Board of the Organisation for the Prohibition of Chemical Weapons on riot control agents in connection to the Chemical Weapons Convention. RSC Advances 2018;8:41731–9. doi: 10.1039/C8RA08273A Timperley C Forman J Aas P Abdollahi M Benachour D Al-Amri A Baulig A Becker-Arnold R Borrett V Carino FA Curty C Gonzalez D Geist M Kane W Kovarik Z Martínez-Alvarez R Mikulak R Mourao N Neffe S Izzati F Advice from the Scientific Advisory Board of the Organisation for the Prohibition of Chemical Weapons on riot control agents in connection to the Chemical Weapons Convention RSC Advances 2018841731 9 doi 10.1039/C8RA08273AOpen DOISearch in Google Scholar

20John H, van der Schans MJ, Koller M, Spruit HET, Worek F, Thiermann H, Noort D. Fatal sarin poisoning in Syria 2013: forensic verification within an international laboratory network. Forensic Toxicol 2018;36:61–71. doi: 10.1007/s11419-017-0376-7 John H van der Schans MJ Koller M Spruit HET Worek F Thiermann H Noort D Fatal sarin poisoning in Syria 2013: forensic verification within an international laboratory network Forensic Toxicol 20183661 71 doi 10.1007/s11419-017-0376-7Open DOISearch in Google Scholar

21Shwirtz M. Nerve agent was used to poison Navalny, chemical weapons body confirms. The New York Times online [displayed 22 November 2020]. Available at https://www.nytimes.com/2020/10/06/world/europe/navalny-opcw-russia-novichok.html Shwirtz M Nerve agent was used to poison Navalny, chemical weapons body confirms The New York Times online [displayed 22 November 2020]. Available at https://www.nytimes.com/2020/10/06/world/europe/navalny-opcw-russia-novichok.htmlSearch in Google Scholar

22Organisation for the Prohibition of Chemical Weapons (OPCW). OPCW issues report on technical assistance requested by Germany [displayed 22 November 2020]. Available at https://www.opcw.org/media-centre/news/2020/10/opcw-issues-report-technical-assistance-requested-germany Organisation for the Prohibition of Chemical Weapons (OPCW) OPCW issues report on technical assistance requested by Germany [displayed 22 November 2020]. Available at https://www.opcw.org/media-centre/news/2020/10/opcw-issues-report-technical-assistance-requested-germanySearch in Google Scholar

23Jokanović M, Stojiljković MP. Current understanding of the application of pyridinium oximes as cholinesterase reactivators in treatment of organophosphate poisoning. Eur J Pharmacol 2006;553:10–17. doi: 10.1016/j. ejphar.2006.09.054 Jokanović M Stojiljković MP Current understanding of the application of pyridinium oximes as cholinesterase reactivators in treatment of organophosphate poisoning Eur J Pharmacol 200655310 17 doi 10.1016/j.ejphar.2006.09.054Open DOISearch in Google Scholar

24Bucht G, Puu G. Aging and reactivatability of plaice cholinesterase inhibited by soman and its stereoisomers. Biochem Pharmacol 1984;33:3573–7. doi: 10.1016/0006-2952(84)90139-4 Bucht G Puu G Aging and reactivatability of plaice cholinesterase inhibited by soman and its stereoisomers Biochem Pharmacol 1984333573 7 doi 10.1016/0006-2952(84)90139-4Open DOISearch in Google Scholar

25Benschop HP, De Jong, LPA. Nerve agent stereoisomers: analysis isolation and toxicology. Acc Chem Res 1988;21:368–74. doi: 10.1021/ar00154a003 Benschop HP De Jong LPA Nerve agent stereoisomers: analysis isolation and toxicology Acc Chem Res 198821368 74 doi 10.1021/ar00154a003Open DOISearch in Google Scholar

26Worek F, Koller M, Thiermann H, Szinicz L. Diagnostic aspects of organophosphate poisoning. Toxicology 2005;214:182–9. doi: 10.1016/j.tox.2005.06.012 Worek F Koller M Thiermann H Szinicz L Diagnostic aspects of organophosphate poisoning Toxicology 2005214182 9 doi 10.1016/j.tox.2005.06.01216051411Open DOISearch in Google Scholar

27Quin DM. Acetylcholinesterase: enzyme structure, reaction dynamics, and virtual transitions states. Chem Rev 1987;78:955–79. doi: 10.1021/cr00081a005 Quin DM Acetylcholinesterase: enzyme structure, reaction dynamics, and virtual transitions states Chem Rev 198778955 79 doi 10.1021/cr00081a005Open DOISearch in Google Scholar

28Taylor P, Radić Z. The cholinesterases: from genes to proteins. Annu Rev Pharmacol Toxicol 1994;34:281–320. doi: 10.1146/annurev.pa.34.040194.001433 Taylor P Radić Z The cholinesterases: from genes to proteins Annu Rev Pharmacol Toxicol 199434281 320 doi 10.1146/annurev.pa.34.040194.0014338042853Open DOISearch in Google Scholar

29Bourne Y, Taylor P, Bougis PE, Marchot P. Crystal structure of mouse acetylcholinesterase. A peripheral site-occluding loop in a tetrameric assembly. J Biol Chem 1999;274:2963–70. doi: 10.1074/jbc.274.5.2963 Bourne Y Taylor P Bougis PE Marchot P Crystal structure of mouse acetylcholinesterase. A peripheral site-occluding loop in a tetrameric assembly J Biol Chem 19992742963 70 doi 10.1074/jbc.274.5.29639915834Open DOISearch in Google Scholar

30Silman I, Sussman JL. Acetylcholinesterase: how is structure related to function? Chem Biol Interact 2008;175:3–10. doi: 10.1016/j.cbi.2008.05.035 Silman I Sussman JL Acetylcholinesterase: how is structure related to function? Chem Biol Interact 20081753 10 doi 10.1016/j.cbi.2008.05.03518586019Open DOISearch in Google Scholar

31Sanson B, Colletier JP, Xu Y, Lang PT, Jiang H, Silman I, Sussman JL, Weik M. Backdoor opening mechanism in acetylcholinesterase based on X-ray crystallography and molecular dynamics simulations. Protein Sci 2011;20:1114–8. doi: 10.1002/pro.661 Sanson B Colletier JP Xu Y Lang PT Jiang H Silman I Sussman JL Weik M Backdoor opening mechanism in acetylcholinesterase based on X-ray crystallography and molecular dynamics simulations Protein Sci 2011201114 8 doi 10.1002/pro.661314918421594947Open DOISearch in Google Scholar

32Çokuğras AN. Butyrylcholinesterase: structure and physiological importance. Turk J Biochem 2003;28:54–61. Çokuğras AN Butyrylcholinesterase: structure and physiological importance Turk J Biochem 20032854 61Search in Google Scholar

33Nicolet Y, Lockridge O, Masson P, Fontecilla-Camps JC, Nachon F. Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products. J Biol Chem 2003;278:41141–7. doi: 10.1074/jbc.M210241200 Nicolet Y Lockridge O Masson P Fontecilla-Camps JC Nachon F Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products J Biol Chem 200327841141 7 doi 10.1074/jbc.M21024120012869558Open DOISearch in Google Scholar

34Chatonnet A, Lockridge O. Comparison of butyrylcholinesterase and acetylcholinesterase. Biochem J 1989;260:625–34. doi: 10.1042/bj2600625 Chatonnet A Lockridge O Comparison of butyrylcholinesterase and acetylcholinesterase Biochem J 1989260625 34 doi 10.1042/bj260062511387242669736Open DOISearch in Google Scholar

35Darvesh S, Hopkins DA, Geula C. Neurobiology of butyrylcholinesterase. Nat Rev Neurosci 2003;4:131–8. doi: 10.1038/nrn1035 Darvesh S Hopkins DA Geula C Neurobiology of butyrylcholinesterase Nat Rev Neurosci 20034131 8 doi 10.1038/nrn103512563284Open DOISearch in Google Scholar

36Grisaru D, Sternfeld M, Eldor A, Glick D, Soreq H. Structural roles of acetylcholinesterase variants in biology and pathology. Eur J Biochem 1999;264:672–86. doi: 10.1046/j.1432-1327.1999.00693.x Grisaru D Sternfeld M Eldor A Glick D Soreq H Structural roles of acetylcholinesterase variants in biology and pathology Eur J Biochem 1999264672 86 doi 10.1046/j.1432-1327.1999.00693.x10491113Open DOISearch in Google Scholar

37Soreq H, Seidman S. Acetylcholinesterase-new roles for an old actor. Nat Rev Neurosci 2001;2:294–302. doi: 10.1038/35067589 Soreq H Seidman S Acetylcholinesterase-new roles for an old actor Nat Rev Neurosci 20012294 302 doi 10.1038/35067589Open DOISearch in Google Scholar

38Bosak A, Gazić I, Vinković V, Kovarik Z. Stereoselective inhibition of human, mouse, and horse cholinesterases by bambuterol enantiomers. Chem Biol Interact 2008;175:192–5. doi: 10.1016/j.cbi.2008.04.050 Bosak A Gazić I Vinković V Kovarik Z Stereoselective inhibition of human, mouse, and horse cholinesterases by bambuterol enantiomers Chem Biol Interact 2008175192 5 doi 10.1016/j.cbi.2008.04.050Open DOISearch in Google Scholar

39Xie W, Stribley JA, Chatonnet A, Wilder PJ, Rizzino A, McComb RD, Taylor P, Hinrichs SH, Lockridge O. Postnatal developmental delay and supersensitivity to organophosphate in gene-targeted mice lacking acetylcholinesterase. J Pharmacol Exp Ther 2000;293:896–902. PMID: 10869390 Xie W Stribley JA Chatonnet A Wilder PJ Rizzino A McComb RD Taylor P Hinrichs SH Lockridge O Postnatal developmental delay and supersensitivity to organophosphate in gene-targeted mice lacking acetylcholinesterase J Pharmacol Exp Ther 2000293896 902 PMID: 10869390Search in Google Scholar

40Bajgar J. Prophylaxis against organophosphorus poisoning. J Med Chem Def 2004;1:1–16. Bajgar J Prophylaxis against organophosphorus poisoning J Med Chem Def 200411 16Search in Google Scholar

41Newmark J. Therapy for nerve agent poisoning. Arch Neurol 2004;61:649–52. doi: 10.1001/archneur.61.5.649 Newmark J Therapy for nerve agent poisoning Arch Neurol 200461649 52 doi 10.1001/archneur.61.5.649Open DOISearch in Google Scholar

42Hobbiger F. Reactivation of phosphorylated acetylcholinesterase. In: Koelle GB, editor. Cholinesterases and anticholinesterase agents. Handbook of experimental pharmacology. Vol. 15. Berlin, Heidelberg: Springer; 1963. p. 921–88. Hobbiger F Reactivation of phosphorylated acetylcholinesterase In Koelle GB editor Cholinesterases and anticholinesterase agents. Handbook of experimental pharmacology. Vol. 15 Berlin, Heidelberg Springer 1963 p 921 8810.1007/978-3-642-99875-1_21Search in Google Scholar

43Holmstedt B. Cholinesterase inhibitors: an introduction. In: Giacobini E, editor. Cholinesterases and cholinesterase inhibitors. London: Martin Dunitz Ltd; 2000. p. 1–8. Holmstedt B Cholinesterase inhibitors: an introduction In Giacobini E editor Cholinesterases and cholinesterase inhibitors London Martin Dunitz Ltd 2000 p 1 8Search in Google Scholar

44Benschop HP, Konings CA, Van Genderen J, De Jong LP. Isolation, anticholinesterase properties, and acute toxicity in mice of the four stereoisomers of the nerve agent soman. Toxicol Appl Pharmacol 1984;72:61–74. doi: 10.1016/0041-008x(84)90249-7 Benschop HP Konings CA Van Genderen J De Jong LP Isolation, anticholinesterase properties, and acute toxicity in mice of the four stereoisomers of the nerve agent soman Toxicol Appl Pharmacol 19847261 74 doi 10.1016/0041-008x(84)90249-7Open DOISearch in Google Scholar

45Reiner E, Radić Z. Mechanism of action of cholinesterase inhibitor. In: Giacobini E, editor. Cholinesterases and cholinesterase inhibitors. London: Martin Dunitz Ltd; 2000. p. 103–19. Reiner E Radić Z Mechanism of action of cholinesterase inhibitor In Giacobini E editor Cholinesterases and cholinesterase inhibitors London Martin Dunitz Ltd 2000 p 103 19Search in Google Scholar

46Bosak A, Katalinić M, Kovarik Z. Kolinesteraze: struktura, uloga, inhibicija [Cholinesterases: structure, role, and inhibition, in Croatian]. Arh Hig Rada Toksikol 2011;62:175–90. doi: 10.2478/10004-1254-62-2011-2107 Bosak A Katalinić M Kovarik Z Kolinesteraze: struktura, uloga, inhibicija [Cholinesterases: structure, role, and inhibition, in Croatian] Arh Hig Rada Toksikol 201162175 90 doi 10.2478/10004-1254-62-2011-210721705306Open DOISearch in Google Scholar

47Millard CB, Koellner G, Ordentlich A, Shafferman A, Silman I, Sussman JL. Reaction products of acetylcholinesterase and VX reveal a mobile histidine in the catalytic triad. J Am Chem Soc 1999;121:9883–4. doi: 10.1021/ja992704i Millard CB Koellner G Ordentlich A Shafferman A Silman I Sussman JL Reaction products of acetylcholinesterase and VX reveal a mobile histidine in the catalytic triad J Am Chem Soc 19991219883 4 doi 10.1021/ja992704iOpen DOISearch in Google Scholar

48Ekström F, Akfur C, Tunemalm AK, Lundberg S. Structural changes of phenylalanine 338 and histidine 447 revealed by the crystal structures of tabun-inhibited murine acetylcholinesterase. Biochemistry 2006;45:74–81. doi: 10.1021/bi051286t Ekström F Akfur C Tunemalm AK Lundberg S Structural changes of phenylalanine 338 and histidine 447 revealed by the crystal structures of tabun-inhibited murine acetylcholinesterase Biochemistry 20064574 81 doi 10.1021/bi051286t16388582Open DOISearch in Google Scholar

49Masson P, Nachon F, Lockridge O. Structural approach to the aging of phosphylated cholinesterases. Chem Biol Interact 2010;187:157–62. doi: 10.1016/j.cbi.2010.03.027 Masson P Nachon F Lockridge O Structural approach to the aging of phosphylated cholinesterases Chem Biol Interact 2010187157 62 doi 10.1016/j.cbi.2010.03.02720338153Open DOISearch in Google Scholar

50Chandar NB, Ganguly B. A first principles investigation of aging processes in soman conjugated AChE. Chem Biol Interact 2013;204:185–90. doi: 10.1016/j.cbi.2013.05.013 Chandar NB Ganguly B A first principles investigation of aging processes in soman conjugated AChE Chem Biol Interact 2013204185 90 doi 10.1016/j.cbi.2013.05.01323747845Open DOISearch in Google Scholar

51de Jong LP, Wolring GZ. Stereospecific reactivation by some Hagedorn-oximes of acetylcholinesterases from various species including man, inhibited by soman. Biochem Pharmacol 1984;33:1119–25. doi: 10.1016/0006-2952(84)90523-9 de Jong LP Wolring GZ Stereospecific reactivation by some Hagedorn-oximes of acetylcholinesterases from various species including man, inhibited by soman Biochem Pharmacol 1984331119 25 doi 10.1016/0006-2952(84)90523-9Open DOISearch in Google Scholar

52Worek F, Thiermann H, Szinicz L, Eyer P. Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes. Biochem Pharmacol 2004;68:2237–48. doi: 10.1016/j.bcp.2004.07.038 Worek F Thiermann H Szinicz L Eyer P Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes Biochem Pharmacol 2004682237 48 doi 10.1016/j.bcp.2004.07.038Open DOISearch in Google Scholar

53Zhuang Q, Franjesevic AJ, Corrigan TS, Coldren WH, Dicken R, Sillart S, DeYong A, Yoshino N, Smith J, Fabry S, Fitzpatrick K, Blanton TG, Joseph J, Yoder RJ, McElroy CA, Ekici ÖD, Callam CS, Hadad CM. Demonstration of in vitro resurrection of aged acetylcholinesterase after exposure to organophosphorus chemical nerve agents. J Med Chem 2018;61:7034–42. doi: 10.1021/acs.jmedchem.7b01620 Zhuang Q Franjesevic AJ Corrigan TS Coldren WH Dicken R Sillart S DeYong A Yoshino N Smith J Fabry S Fitzpatrick K Blanton TG Joseph J Yoder RJ McElroy CA Ekici ÖD Callam CS Hadad CM Demonstration of in vitro resurrection of aged acetylcholinesterase after exposure to organophosphorus chemical nerve agents J Med Chem 2018617034 42 doi 10.1021/acs.jmedchem.7b01620Open DOISearch in Google Scholar

54Shih TM, Rowland TC, McDonough JH. Anticonvulsants for nerve agentinduced seizures: the influence of the therapeutic dose of atropine. J Pharmacol Exp Ther 2007;320:154–61. doi: 10.1124/jpet.106.111252 Shih TM Rowland TC McDonough JH Anticonvulsants for nerve agentinduced seizures: the influence of the therapeutic dose of atropine J Pharmacol Exp Ther 2007320154 61 doi 10.1124/jpet.106.111252Open DOISearch in Google Scholar

55Thiermann H, Steinritz D, Worek F, Radtke B, Eyer P, Eyer F, Felgenhauer N, Zilker T. Atropine maintenance dosage in patients with severe organophosphate pesticide poisoning. Toxicol Lett 2011;206:77–83. doi: 10.1016/j. toxlet.2011.07.006 Thiermann H Steinritz D Worek F Radtke B Eyer P Eyer F Felgenhauer N Zilker T Atropine maintenance dosage in patients with severe organophosphate pesticide poisoning Toxicol Lett 201120677 83 doi 10.1016/j.toxlet.2011.07.006Open DOISearch in Google Scholar

56Sidell FR, Newmark J, McDonough JH. Nerve agents. In: Lenhart MK, Tuorinsky SD, editors. Textbooks of military medicine, medical aspects of chemical warfare. Washington (DC): Department of the Army USA; 2008. p. 155–219. Sidell FR Newmark J McDonough JH Nerve agents In Lenhart MK Tuorinsky SD editors Textbooks of military medicine, medical aspects of chemical warfare Washington (DC) Department of the Army USA 2008 p 155 219Search in Google Scholar

57Childs AF, Davies DR, Green AL, Rutland JP. The reactivation by oximes and hydroxamic acids of cholinesterase inhibited by organo-phosphorus compounds. Br J Pharmacol Chemother 1955;10:462–5. doi: 10.1111/j.1476-5381.1955. tb00106.x Childs AF Davies DR Green AL Rutland JP The reactivation by oximes and hydroxamic acids of cholinesterase inhibited by organo-phosphorus compounds Br J Pharmacol Chemother 195510462 5 doi 10.1111/j.1476-5381.1955.tb00106.xOpen DOISearch in Google Scholar

58Wilson IB, Ginsburg S. Reactivation of acetylcholinesterase inhibited by alkylphosphates. Arch Biochem Biophys 1955;54:569–71. doi: 10.1016/0003-9861(55)90075-8 Wilson IB Ginsburg S Reactivation of acetylcholinesterase inhibited by alkylphosphates Arch Biochem Biophys 195554569 71 doi 10.1016/0003-9861(55)90075-8Open DOISearch in Google Scholar

59Rousseaux CG, Dua AK. Pharmacology of HI-6, an H-series oxime. Can J Physiol Pharmacol 1989;67:1183–9. doi: 10.1139/y89-188 Rousseaux CG Dua AK Pharmacology of HI-6, an H-series oxime Can J Physiol Pharmacol 1989671183 9 doi 10.1139/y89-1882692793Open DOISearch in Google Scholar

60Eyer P. In memory of Ilse Hagedorn. Toxicology 2007;233:3–7. doi: 10.1016/j.tox.2006.09.014 Eyer P In memory of Ilse Hagedorn Toxicology 20072333 7 doi 10.1016/j.tox.2006.09.01417511052Open DOISearch in Google Scholar

61Worek F, Thiermann H, Wille T. Oximes in organophosphate poisoning: 60 years of hope and despair. Chem Biol Interact 2016;259(Pt B):93–8. doi: 10.1016/j.cbi.2016.04.032 Worek F Thiermann H Wille T Oximes in organophosphate poisoning: 60 years of hope and despair Chem Biol Interact 2016259Pt B93 8 doi 10.1016/j.cbi.2016.04.03227125761Open DOISearch in Google Scholar

62Dawson RM. Review of oximes available for treatment of nerve agent poisoning. J Appl Toxicol 1994;14:317–31. doi: 10.1002/jat.2550140502 Dawson RM Review of oximes available for treatment of nerve agent poisoning J Appl Toxicol 199414317 31 doi 10.1002/jat.2550140502Open DOISearch in Google Scholar

63Antonijević B, Stojiljković MP. Unequal efficacy of pyridinium oximes in acute organophosphate poisoning. Clin Med Res 2007;5:71–82. doi: 10.3121/cmr.2007.701 Antonijević B Stojiljković MP Unequal efficacy of pyridinium oximes in acute organophosphate poisoning Clin Med Res 2007571 82 doi 10.3121/cmr.2007.701Open DOISearch in Google Scholar

64Thiermann H, Worek F, Kehe K. Limitations and challenges in treatment of acute chemical warfare agent poisoning. Chem Biol Interact 2013;206:435–43. doi: 10.1016/j. cbi.2013.09.015 Thiermann H Worek F Kehe K Limitations and challenges in treatment of acute chemical warfare agent poisoning Chem Biol Interact 2013206435 43 doi 10.1016/j.cbi.2013.09.015Open DOISearch in Google Scholar

65Thiermann H, Szinicz L, Eyer F, Worek F, Eyer P, Felgenhauer N, Zilker T. Modern strategies in therapy of organophosphate poisoning. Toxicol Lett 1999;107:233–9. doi: 10.1016/s0378-4274(99)00052-1 Thiermann H Szinicz L Eyer F Worek F Eyer P Felgenhauer N Zilker T Modern strategies in therapy of organophosphate poisoning Toxicol Lett 1999107233 9 doi 10.1016/s0378-4274(99)00052-1Open DOISearch in Google Scholar

66Worek F, Szinicz L, Eyer P, Thiermann H. Evaluation of oxime efficacy in nerve agent poisoning: development of a kinetic-based dynamic model. Toxicol Appl Pharmacol 2005;209:193–202. doi: 10.1016/j.taap.2005.04.006 Worek F Szinicz L Eyer P Thiermann H Evaluation of oxime efficacy in nerve agent poisoning: development of a kinetic-based dynamic model Toxicol Appl Pharmacol 2005209193 202 doi 10.1016/j.taap.2005.04.00615904945Open DOISearch in Google Scholar

67Lorke DE, Kalasz H, Petroianu GA, Tekes K. Entry of oximes into the brain: a review. Curr Med Chem 2008;15:743–53. doi: 10.2174/092986708783955563 Lorke DE Kalasz H Petroianu GA Tekes K Entry of oximes into the brain: a review Curr Med Chem 200815743 53 doi 10.2174/09298670878395556318393843Open DOISearch in Google Scholar

68Kovarik Z, Radić Z, Berman HA, Simeon-Rudolf V, Reiner E, Taylor P. Mutant cholinesterases possessing enhanced capacity for reactivation of their phosphonylated conjugates. Biochemistry 2004;43:3222–9. doi: 10.1021/bi036191a Kovarik Z Radić Z Berman HA Simeon-Rudolf V Reiner E Taylor P Mutant cholinesterases possessing enhanced capacity for reactivation of their phosphonylated conjugates Biochemistry 2004433222 9 doi 10.1021/bi036191a15023072Open DOISearch in Google Scholar

69Kovarik Z, Čalić M, Šinko G, Bosak A, Berend S, Lucić Vrdoljak A, Radić B. Oximes: Reactivators of phosphorylated acetylcholinesterase and antidotes in therapy against tabun poisoning. Chem Biol Interact 2008;175:173–9. doi: 10.1016/j.cbi.2008.04.011 Kovarik Z Čalić M Šinko G Bosak A Berend S Lucić Vrdoljak A Radić B Oximes: Reactivators of phosphorylated acetylcholinesterase and antidotes in therapy against tabun poisoning Chem Biol Interact 2008175173 9 doi 10.1016/j.cbi.2008.04.01118501341Open DOISearch in Google Scholar

70Kovarik Z, Katalinić M, Šinko G, Binder J, Holas O, Jung YS, Musilova L, Jun D, Kuča K. Pseudo-catalytic scavenging: Searching for a suitable reactivator of phosphorylated butyrylcholinesterase. Chem Biol Interact 2010;187:167–71. doi: 10.1016/j.cbi.2010.02.023 Kovarik Z Katalinić M Šinko G Binder J Holas O Jung YS Musilova L Jun D Kuča K Pseudo-catalytic scavenging: Searching for a suitable reactivator of phosphorylated butyrylcholinesterase Chem Biol Interact 2010187167 71 doi 10.1016/j.cbi.2010.02.02320206154Open DOISearch in Google Scholar

71Kovarik Z, Maček Hrvat N, Katalinić M, Sit RK, Paradyse A, Žunec S, Musilek K, Fokin VV, Taylor P, Radić Z. Catalytic soman scavenging by the Y337A/F338A acetylcholinesterase mutant assisted with novel site-directed aldoximes. Chem Res Toxicol 2015;28:1036–44. doi: 10.1021/acs.chemrestox.5b00060 Kovarik Z Maček Hrvat N Katalinić M Sit RK Paradyse A Žunec S Musilek K Fokin VV Taylor P Radić Z Catalytic soman scavenging by the Y337A/F338A acetylcholinesterase mutant assisted with novel site-directed aldoximes Chem Res Toxicol 2015281036 44 doi 10.1021/acs.chemrestox.5b00060479109825835984Open DOISearch in Google Scholar

72Worek F, Reiter G, Eyer P, Szinicz L. Reactivation kinetics of acetylcholinesterase from different species inhibited by highly toxic organophosphates. Arch Toxicol 2002;76:523–9. doi: 10.1007/s00204-002-0375-1 Worek F Reiter G Eyer P Szinicz L Reactivation kinetics of acetylcholinesterase from different species inhibited by highly toxic organophosphates Arch Toxicol 200276523 9 doi 10.1007/s00204-002-0375-112242610Open DOISearch in Google Scholar

73Ekström F, Pang YP, Boman M, Artursson E, Akfur C, Börjegren S. Crystal structures of acetylcholinesterase in complex with HI-6, Ortho-7 and obidoxime: structural basis for differences in the ability to reactivate tabun conjugates. Biochem Pharmacol 2006;72:597–607. doi: 10.1016/j. bcp.2006.05.027 Ekström F Pang YP Boman M Artursson E Akfur C Börjegren S Crystal structures of acetylcholinesterase in complex with HI-6, Ortho-7 and obidoxime: structural basis for differences in the ability to reactivate tabun conjugates Biochem Pharmacol 200672597 607 doi 10.1016/j.bcp.2006.05.02716876764Open DOISearch in Google Scholar

74Kovarik Z, Kalisiak J, Maček Hrvat N, Katalinić M, Zorbaz T, Žunec S, Green C, Radić Z, Fokin VV, Sharpless KB, Taylor P. Reversal of tabun toxicity enabled by a triazole annulated oxime library-reactivators of acetylcholinesterase. Chem Eur J 2019;25:4100–14. doi: 10.1002/chem.201805051 Kovarik Z Kalisiak J Maček Hrvat N Katalinić M Zorbaz T Žunec S Green C Radić Z Fokin VV Sharpless KB Taylor P Reversal of tabun toxicity enabled by a triazole annulated oxime library-reactivators of acetylcholinesterase Chem Eur J 2019254100 14 doi 10.1002/chem.20180505130458057Open DOISearch in Google Scholar

75Kovarik Z, Ciban N, Radić Z, Simeon-Rudolf V, Taylor P. Active site mutant acetylcholinesterase interactions with 2-PAM, HI-6, and DDVP. Biochem Biophys Res Commun 2006;342(3):973–8. doi: 10.1016/j.bbrc.2006.02.056 Kovarik Z Ciban N Radić Z Simeon-Rudolf V Taylor P Active site mutant acetylcholinesterase interactions with 2-PAM, HI-6, and DDVP Biochem Biophys Res Commun 20063423973 8 doi 10.1016/j.bbrc.2006.02.05616598855Open DOISearch in Google Scholar

76de Koning MC, Joosen MJ, Noort D, van Zuylen A, Tromp MC. Peripheral site ligand-oxime conjugates: A novel concept towards reactivation of nerve agent-inhibited human acetylcholinesterase. Bioorg Med Chem 2011;19:588–94. doi: 10.1016/j.bmc.2010.10.059 de Koning MC Joosen MJ Noort D van Zuylen A Tromp MC Peripheral site ligand-oxime conjugates: A novel concept towards reactivation of nerve agent-inhibited human acetylcholinesterase Bioorg Med Chem 201119588 94 doi 10.1016/j.bmc.2010.10.05921112787Open DOISearch in Google Scholar

77Maraković N, Knežević A, Vinković V, Kovarik Z, Šinko G. Design and synthesis of N -substituted-2-hydroxyiminoacetamides and interactions with cholinesterases. Chem Biol Interact 2016;259:122–32. doi: 10.1016/j.cbi.2016.05.035 Maraković N Knežević A Vinković V Kovarik Z Šinko G Design and synthesis of N -substituted-2-hydroxyiminoacetamides and interactions with cholinesterases Chem Biol Interact 2016259122 32 doi 10.1016/j.cbi.2016.05.03527238725Open DOISearch in Google Scholar

78Kovarik Z, Maček Hrvat N, Kalisiak J, Katalinić M, Sit RK, Zorbaz T, Radić Z, Fokin VV, Sharpless KB, Taylor P. Counteracting tabun inhibition by reactivation by pyridinium aldoximes interacting with active center gorge mutations of acetylcholinesterase. Toxicol Appl Pharmacol 2019;372:40–6. doi: 10.1016/j.taap.2019.04.007 Kovarik Z Maček Hrvat N Kalisiak J Katalinić M Sit RK Zorbaz T Radić Z Fokin VV Sharpless KB Taylor P Counteracting tabun inhibition by reactivation by pyridinium aldoximes interacting with active center gorge mutations of acetylcholinesterase Toxicol Appl Pharmacol 201937240 6 doi 10.1016/j.taap.2019.04.00730978400Open DOISearch in Google Scholar

79Maček Hrvat N, Kalisiak J, Šinko G, Radić Z, Sharpless KB, Taylor P, Kovarik Z. Evaluation of high-affinity phenyltetrahydroisoquinoline aldoximes, linked through anti-triazoles, as reactivators of phosphylated cholinesterases. Toxicol Lett 2020;321:83–9. doi: 10.1016/j.toxlet.2019.12.016 Maček Hrvat N Kalisiak J Šinko G Radić Z Sharpless KB Taylor P Kovarik Z Evaluation of high-affinity phenyltetrahydroisoquinoline aldoximes, linked through anti-triazoles, as reactivators of phosphylated cholinesterases Toxicol Lett 202032183 9 doi 10.1016/j.toxlet.2019.12.016705343131863869Open DOISearch in Google Scholar

80Primožič I, Odžak R, Tomić S, Simeon-Rudolf V, Reiner E. Pyridinium, imidazolium, and quinucludinium oximes: synthesis, interaction with native and phosphylated cholinesterases, and antidotes against organophosphorus compounds. J Med Chem Def 2004;2:1–30. Primožič I Odžak R Tomić S Simeon-Rudolf V Reiner E Pyridinium, imidazolium, and quinucludinium oximes: synthesis, interaction with native and phosphylated cholinesterases, and antidotes against organophosphorus compounds J Med Chem Def 200421 30Search in Google Scholar

81Oh KA, Yang GY, Jun D, Kuca K, Jung YS. Bispyridiumaldoxime reactivators connected with CH₂O(CH₂ n OCH2 linkers between pyridinium rings and their reactivity against VX. Bioorg Med Chem Lett 2006;16:4852–5. doi: 10.1016/j.bmcl.2006.06.063 Oh KA Yang GY Jun D Kuca K Jung YS Bispyridiumaldoxime reactivators connected with CH₂O(CH₂ n OCH2 linkers between pyridinium rings and their reactivity against VX Bioorg Med Chem Lett 2006164852 5 doi 10.1016/j.bmcl.2006.06.06316828550Open DOISearch in Google Scholar

82Musilek K, Holas O, Jun D, Dohnal V, Gunn-Moore F, Opletalova V, Dolezal M, Kuca K. Monooxime reactivators of acetylcholinesterase with E-but-2-ene linker: preparation and reactivation of tabun- and paraoxon-inhibited acetylcholinesterase. Bioorg Med Chem 2007;15:6733–41. doi: 10.1016/j.bmc.2007.08.002 Musilek K Holas O Jun D Dohnal V Gunn-Moore F Opletalova V Dolezal M Kuca K Monooxime reactivators of acetylcholinesterase with E-but-2-ene linker: preparation and reactivation of tabun- and paraoxon-inhibited acetylcholinesterase Bioorg Med Chem 2007156733 41 doi 10.1016/j.bmc.2007.08.00217764957Open DOISearch in Google Scholar

83Acharya J, Dubey DK, Srivastava AK, Raza SK. In vitro reactivation of sarin-inhibited human acetylcholinesterase (AChE) by bis-pyridinium oximes connected by xylene linkers. Toxicol In Vitro 2011;25:251–6. doi: 10.1016/j. tiv.2010.07.024 Acharya J Dubey DK Srivastava AK Raza SK. In vitro reactivation of sarin-inhibited human acetylcholinesterase (AChE) by bis-pyridinium oximes connected by xylene linkers Toxicol In Vitro 201125251 6 doi 10.1016/j.tiv.2010.07.024Open DOISearch in Google Scholar

84Čalić M, Bosak A, Šinko G, Jelić D. In vitro evaluation of aldoxime interactions with human acetylcholinesterase. Croat Chem Acta 2008;81:47–57. Čalić M Bosak A Šinko G Jelić D In vitro evaluation of aldoxime interactions with human acetylcholinesterase Croat Chem Acta 20088147 57Search in Google Scholar

85Kryger G, Silman I, Sussman JL. Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs. Structure 1999;7:297–307. doi: 10.1016/s0969-2126(99)80040-9 Kryger G Silman I Sussman JL Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs Structure 19997297 307 doi 10.1016/s0969-2126(99)80040-9Open DOISearch in Google Scholar

86McHardy SF, Bohmann JA, Corbett MR, Campos B, Tidwell MW, Thompson PM, Bemben CJ, Menchaca TA, Reeves TE, Cantrell WRJr, Bauta WE, Lopez A, Maxwell DM, Brecht KM, Sweeney RE, McDonough J. Design, synthesis, and characterization of novel, nonquaternary reactivators of GF-inhibited human acetylcholinesterase. Bioorg Med Chem Lett 2014;24:1711–4. doi: 10.1016/j.bmcl.2014.02.049 McHardy SF Bohmann JA Corbett MR Campos B Tidwell MW Thompson PM Bemben CJ Menchaca TA Reeves TE Cantrell WRJr Bauta WE Lopez A Maxwell DM Brecht KM Sweeney RE McDonough J Design, synthesis, and characterization of novel, nonquaternary reactivators of GF-inhibited human acetylcholinesterase Bioorg Med Chem Lett 2014241711 4 doi 10.1016/j.bmcl.2014.02.04924630558Open DOISearch in Google Scholar

87Renou J, Dias J, Mercey G, Verdelet T, Rousseau C, Gastellier A-J, Arboleas M, Touvrey-Loiodice M, Baati R, Jean L, Nachon F, Renard P-Y. Synthesis and in vitro evaluation of donepezil- based reactivators and analogues for nerve agent-inhibited human acetylcholinesterase. RSC Adv 2016;6:17929–40. doi: 10.1039/C5RA25477A Renou J Dias J Mercey G Verdelet T Rousseau C Gastellier A-J Arboleas M Touvrey-Loiodice M Baati R Jean L Nachon F Renard P-Y Synthesis and in vitro evaluation of donepezil- based reactivators and analogues for nerve agent-inhibited human acetylcholinesterase RSC Adv 2016617929 40 doi 10.1039/C5RA25477AOpen DOISearch in Google Scholar

88de Koning MC, van Grol M, Noort D. Peripheral site ligand conjugation to a non-quaternary oxime enhances reactivation of nerve agent-inhibited human acetylcholinesterase. Toxicol Lett 2011;206:54–9. doi: 10.1016/j.toxlet.2011.04.004 de Koning MC van Grol M Noort D Peripheral site ligand conjugation to a non-quaternary oxime enhances reactivation of nerve agent-inhibited human acetylcholinesterase Toxicol Lett 201120654 9 doi 10.1016/j.toxlet.2011.04.00421504785Open DOISearch in Google Scholar

89Kliachyna M, Santoni G, Nussbaum V, Renou J, Sanson B, Colletier J-P, Arboléas M, Loiodice M, Weik M, Jean L, Renard P-Y, Nachon F, Baati R. Design, synthesis and biological evaluation of novel tetrahydroacridine pyridinealdoxime and -amidoxime hybrids as efficient uncharged reactivators of nerve agent-inhibited human acetylcholinesterase. Eur J Med Chem 2014;78:455–67. doi: 10.1016/j.ejmech.2014.03.044 Kliachyna M Santoni G Nussbaum V Renou J Sanson B Colletier J-P Arboléas M Loiodice M Weik M Jean L Renard P-Y Nachon F Baati R Design, synthesis and biological evaluation of novel tetrahydroacridine pyridinealdoxime and -amidoxime hybrids as efficient uncharged reactivators of nerve agent-inhibited human acetylcholinesterase Eur J Med Chem 201478455 67 doi 10.1016/j.ejmech.2014.03.04424704618Open DOISearch in Google Scholar

90Renou J, Loiodice M, Arboléas M, Baati R, Jean L, Nachon F, Renard P-Y. Tryptoline-3-hydroxypyridinaldoxime conjugates as efficient reactivators of phosphylated human acetyl and butyrylcholinesterases. Chem Commun 2014;50:3947–50. doi: 10.1039/C4CC00561A Renou J Loiodice M Arboléas M Baati R Jean L Nachon F Renard P-Y Tryptoline-3-hydroxypyridinaldoxime conjugates as efficient reactivators of phosphylated human acetyl and butyrylcholinesterases Chem Commun 2014503947 50 doi 10.1039/C4CC00561AOpen DOISearch in Google Scholar

91Zorbaz T, Braïki A, Maraković N, Renou J, de la Mora E, Maček Hrvat N, Katalinić M, Silman I, Sussman JL, Mercey G, Gomez C, Mougeot R, Pérez B, Baati R, Nachon F, Weik M, Jean L, Kovarik Z, Renard P-Y. Potent 3-hydroxy-2-pyridine aldoxime reactivators of organophosphate-inhibited cholinesterases with predicted blood-brain barrier penetration. Chem Eur J 2018;24:9675–91. doi: 10.1002/chem.201801394 Zorbaz T Braïki A Maraković N Renou J de la Mora E Maček Hrvat N Katalinić M Silman I Sussman JL Mercey G Gomez C Mougeot R Pérez B Baati R Nachon F Weik M Jean L Kovarik Z Renard P-Y Potent 3-hydroxy-2-pyridine aldoxime reactivators of organophosphate-inhibited cholinesterases with predicted blood-brain barrier penetration Chem Eur J 2018249675 91 doi 10.1002/chem.20180139429672968Open DOISearch in Google Scholar

92Mercey G, Verdelet T, Saint-André G, Gillon E, Wagner A, Baati R, Jean L, Nachon F, Renard P-Y. First efficient uncharged reactivators for the dephosphylation of poisoned human acetylcholinesterase. Chem Commun 2011;47:5295–7. doi: 10.1039/C1CC10787A Mercey G Verdelet T Saint-André G Gillon E Wagner A Baati R Jean L Nachon F Renard P-Y First efficient uncharged reactivators for the dephosphylation of poisoned human acetylcholinesterase Chem Commun 2011475295 7 doi 10.1039/C1CC10787AOpen DOISearch in Google Scholar

93Mercey G, Renou J, Verdelet T, Kliachyna M, Baati R, Gillon E, Arboléas M, Loiodice M, Nachon F, Jean L, Renard P-Y. Phenyltetrahydroisoquinoline-pyridinaldoxime conjugates as efficient uncharged reactivators for the dephosphylation of inhibited human acetylcholinesterase. J Med Chem 2012;55:10791–5. doi: 10.1021/jm3015519 Mercey G Renou J Verdelet T Kliachyna M Baati R Gillon E Arboléas M Loiodice M Nachon F Jean L Renard P-Y Phenyltetrahydroisoquinoline-pyridinaldoxime conjugates as efficient uncharged reactivators for the dephosphylation of inhibited human acetylcholinesterase J Med Chem 20125510791 5 doi 10.1021/jm301551923148598Open DOISearch in Google Scholar

94Kalisiak J, Ralph EC, Zhang J, Cashman JR. Amidineoximes: reactivators for organophosphate exposure. J Med Chem 2011;54:3319–30. doi: 10.1021/jm200054r Kalisiak J Ralph EC Zhang J Cashman JR Amidineoximes: reactivators for organophosphate exposure J Med Chem 2011543319 30 doi 10.1021/jm200054r21438612Open DOISearch in Google Scholar

95Sit RK, Radić Z, Gerardi V, Zhang L, Garcia E, Katalinić M, Amitai G, Kovarik Z, Fokin VV, Sharpless KB, Taylor P. New structural scaffolds for centrally acting oxime reactivators of phosphylated cholinesterases. J Biol Chem 2011;286:19422–30. doi: 10.1074/jbc.M111.230656 Sit RK Radić Z Gerardi V Zhang L Garcia E Katalinić M Amitai G Kovarik Z Fokin VV Sharpless KB Taylor P New structural scaffolds for centrally acting oxime reactivators of phosphylated cholinesterases J Biol Chem 201128619422 30 doi 10.1074/jbc.M111.230656310332121464125Open DOISearch in Google Scholar

96Kalisiak J, Ralph EC, Cashman JR. Nonquaternary reactivators for organophosphate-inhibited cholinesterases. J Med Chem 2012;55:465–74. doi: 10.1021/jm201364d Kalisiak J Ralph EC Cashman JR Nonquaternary reactivators for organophosphate-inhibited cholinesterases J Med Chem 201255465 74 doi 10.1021/jm201364d22206546Open DOISearch in Google Scholar

97Radić Z, Sit RK, Kovarik Z, Berend S, Garcia E, Zhang L, Amitai G, Green C, Radić B, Fokin VV, Sharpless KB, Taylor P. Refinement of structural leads for centrally acting oxime reactivators of phosphylated cholinesterases. J Biol Chem 2012;287:11798–809. doi: 10.1074/jbc.M111.333732 Radić Z Sit RK Kovarik Z Berend S Garcia E Zhang L Amitai G Green C Radić B Fokin VV Sharpless KB Taylor P Refinement of structural leads for centrally acting oxime reactivators of phosphylated cholinesterases J Biol Chem 201228711798 809 doi 10.1074/jbc.M111.333732332092822343626Open DOISearch in Google Scholar

98Chambers JE, Chambers HW, Meek EC, Pringle RB. Testing of novel brain-penetrating oxime reactivators of acetylcholinesterase inhibited by nerve agent surrogates. Chem Biol Interact 2013;203:135–8. doi: 10.1016/j. cbi.2012.10.017 Chambers JE Chambers HW Meek EC Pringle RB Testing of novel brain-penetrating oxime reactivators of acetylcholinesterase inhibited by nerve agent surrogates Chem Biol Interact 2013203135 8 doi 10.1016/j.cbi.2012.10.01723123249Open DOISearch in Google Scholar

99Kovarik Z, Maček N, Sit RK, Radić Z, Fokin VV, Barry Sharpless K, Taylor P. Centrally acting oximes in reactivation of tabun-phosphoramidated AChE. Chem Biol Interact 2013;203:77–80. doi: 10.1016/j.cbi.2012.08.019 Kovarik Z Maček N Sit RK Radić Z Fokin VV Barry Sharpless K Taylor P Centrally acting oximes in reactivation of tabun-phosphoramidated AChE Chem Biol Interact 201320377 80 doi 10.1016/j.cbi.2012.08.019353064322960624Open DOISearch in Google Scholar

100Sit RK, Kovarik Z, Maček Hrvat N, Žunec S, Green C, Fokin VV, Sharpless KB, Radić Z, Taylor P. Pharmacology, pharmacokinetics, and tissue disposition of zwitterionic hydroxyiminoacetamido alkylamines as reactivating antidotes for organophosphate exposure. J Pharmacol Exp Ther 2018;367:363–72. doi: 10.1124/jpet.118.249383 Sit RK Kovarik Z Maček Hrvat N Žunec S Green C Fokin VV Sharpless KB Radić Z Taylor P Pharmacology, pharmacokinetics, and tissue disposition of zwitterionic hydroxyiminoacetamido alkylamines as reactivating antidotes for organophosphate exposure J Pharmacol Exp Ther 2018367363 72 doi 10.1124/jpet.118.249383622319430190337Open DOISearch in Google Scholar

101Taylor P, Yan-Jye S, Momper J, Hou W, Camacho-Hernandez GA, Radić Z, Rosenberg Y, Kovarik Z, Sit R, Sharpless KB. Assessment of ionizable, zwitterionic oximes as reactivating antidotal agents for organophosphate exposure. Chem Biol Interact 2019;308:194–7. doi: 10.1016/j.cbi.2019.05.015 Taylor P Yan-Jye S Momper J Hou W Camacho-Hernandez GA Radić Z Rosenberg Y Kovarik Z Sit R Sharpless KB Assessment of ionizable, zwitterionic oximes as reactivating antidotal agents for organophosphate exposure Chem Biol Interact 2019308194 7 doi 10.1016/j.cbi.2019.05.01531100277Open DOISearch in Google Scholar

102Rosenberg YJ, Mao L, Jiang X, Lees J, Zhang L, Radić Z, Taylor P. Post-exposure treatment with the oxime RS194B rapidly reverses early and advanced symptoms in macaques exposed to sarin vapor. Chem Biol Interact 2017;274:50–7. doi: 10.1016/j.cbi.2017.07.003 Rosenberg YJ Mao L Jiang X Lees J Zhang L Radić Z Taylor P Post-exposure treatment with the oxime RS194B rapidly reverses early and advanced symptoms in macaques exposed to sarin vapor Chem Biol Interact 201727450 7 doi 10.1016/j.cbi.2017.07.003558650728693885Open DOISearch in Google Scholar

103Rosenberg YJ, Wang J, Ooms T, Rajendran N, Mao L, Jiang X, Lees J, Urban L, Momper JD, Sepulveda Y, Shyong YJ, Taylor P. Post-exposure treatment with the oxime RS194B rapidly reactivates and reverses advanced symptoms of lethal inhaled paraoxon in macaques. Toxicol Lett 2018;293:229–34. doi: 10.1016/j.toxlet.2017.10.025 Rosenberg YJ Wang J Ooms T Rajendran N Mao L Jiang X Lees J Urban L Momper JD Sepulveda Y Shyong YJ Taylor P Post-exposure treatment with the oxime RS194B rapidly reactivates and reverses advanced symptoms of lethal inhaled paraoxon in macaques Toxicol Lett 2018293229 34 doi 10.1016/j.toxlet.2017.10.025594318129129799Open DOISearch in Google Scholar

104Kreuter J, Alyautdin RN, Kharkevich DA, Ivanov AA. Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles). Brain Res 1995;674:171–4. doi: 10.1016/0006-8993(95)00023-j Kreuter J Alyautdin RN Kharkevich DA Ivanov AA Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles) Brain Res 1995674171 4 doi 10.1016/0006-8993(95)00023-jOpen DOISearch in Google Scholar

105Wagner S, Kufleitner J, Zensi A, Dadparvar M, Wien S, Bungert J, Vogel T, Worek F, Kreuter J, Briesen HV. Nanoparticulate transport of oximes over an in vitro blood-brain barrier model. PLoS One 2010;5(12):e14213. doi: 10.1371/journal.pone.0014213 Wagner S Kufleitner J Zensi A Dadparvar M Wien S Bungert J Vogel T Worek F Kreuter J Briesen HV Nanoparticulate transport of oximes over an in vitro blood-brain barrier model PLoS One 2010512e14213 doi 10.1371/journal.pone.0014213Open DOISearch in Google Scholar

106Demar JC, Clarkson ED, Ratcliffe RH, Campbell AJ, Thangavelu SG, Herdman CA, Leader H, Schulz SM, Marek E, Medynets MA, Ku TC, Evans SA, Khan FA, Owens RR, Nambiar MP, Gordon RK. Pro-2-PAM therapy for central and peripheral cholinesterases. Chem Biol Interact 2010;187:191–8. doi: 10.1016/j.cbi.2010.02.015 Demar JC Clarkson ED Ratcliffe RH Campbell AJ Thangavelu SG Herdman CA Leader H Schulz SM Marek E Medynets MA Ku TC Evans SA Khan FA Owens RR Nambiar MP Gordon RK Pro-2-PAM therapy for central and peripheral cholinesterases Chem Biol Interact 2010187191 8 doi 10.1016/j.cbi.2010.02.015Open DOISearch in Google Scholar

107Jeong HC, Park NJ, Chae CH, Musilek K, Kassa J, Kuča K, Jung Y-S. Fluorinated pyridinium oximes as potential reactivators for acetylcholinesterases inhibited by paraoxon organophosphorus agent. Bioorg Med Chem 2009;17:6213–7. doi: 10.1016/j.bmc.2009.07.043 Jeong HC Park NJ Chae CH Musilek K Kassa J Kuča K Jung Y-S Fluorinated pyridinium oximes as potential reactivators for acetylcholinesterases inhibited by paraoxon organophosphorus agent Bioorg Med Chem 2009176213 7 doi 10.1016/j.bmc.2009.07.043Open DOISearch in Google Scholar

108Zorbaz T, Malinak D, Maraković N, Maček Hrvat N, Zandona A, Novotny M, Skarka A, Andrys R, Benkova M, Soukup O, Katalinić M, Kuca K, Kovarik Z, Musilek K. Pyridinium oximes with ortho-positioned chlorine moiety exhibit improved physicochemical properties and efficient reactivation of human acetylcholinesterase inhibited by several nerve agents. J Med Chem 2018;61:10753–66. doi: 10.1021/acs.jmedchem.8b01398 Zorbaz T Malinak D Maraković N Maček Hrvat N Zandona A Novotny M Skarka A Andrys R Benkova M Soukup O Katalinić M Kuca K Kovarik Z Musilek K Pyridinium oximes with ortho-positioned chlorine moiety exhibit improved physicochemical properties and efficient reactivation of human acetylcholinesterase inhibited by several nerve agents J Med Chem 20186110753 66 doi 10.1021/acs.jmedchem.8b01398Open DOISearch in Google Scholar

109Joosen MJ, van der Schans MJ, van Dijk CG, Kuijpers WC, Wortelboer HM, van Helden HP. Increasing oxime efficacy by blood-brain barrier modulation. Toxicol Lett 2011;206:67–71. doi: 10.1016/j.toxlet.2011.05.231 Joosen MJ van der Schans MJ van Dijk CG Kuijpers WC Wortelboer HM van Helden HP Increasing oxime efficacy by blood-brain barrier modulation Toxicol Lett 201120667 71 doi 10.1016/j.toxlet.2011.05.231Open DOISearch in Google Scholar

110Heldman E, Ashani Y, Raveh L, Rachaman ES. Sugar conjugates of pyridinium aldoximes as antidotes against organophosphate poisoning. Carbohydr Res 1986;151:337–47. doi: 10.1016/s0008-6215(00)90353–7 Heldman E Ashani Y Raveh L Rachaman ES Sugar conjugates of pyridinium aldoximes as antidotes against organophosphate poisoning Carbohydr Res 1986151337 47 doi 10.1016/s0008-6215(00)90353–7Open DOISearch in Google Scholar

111Garcia GE, Campbell AJ, Olson J, Moorad-Doctor D, Morthole VI. Novel oximes as blood-brain barrier penetrating cholinesterase reactivators. Chem Biol Interact 2010;187:199–206. doi: 10.1016/j.cbi.2010.02.033 Garcia GE Campbell AJ Olson J Moorad-Doctor D Morthole VI Novel oximes as blood-brain barrier penetrating cholinesterase reactivators Chem Biol Interact 2010187199 206 doi 10.1016/j.cbi.2010.02.03320227398Open DOISearch in Google Scholar

112Eto M. Organic and biological chemistry. In: Zweig G, editor. The organophosphorus pesticides. Cleveland: CRC Press Inc; 1976. p. 142. Eto M Organic and biological chemistry In Zweig G editor The organophosphorus pesticides Cleveland CRC Press Inc 1976 p 142Search in Google Scholar

113Cabal J, Kuca K, Kassa J. Specification of the structure of oximes able to reactivate tabun-inhibited acetylcholinesterase. Basic Clin Pharmacol Toxicol 2004;95:81–6. doi: 10.1111/j.1742-7843.2004.950207.x Cabal J Kuca K Kassa J Specification of the structure of oximes able to reactivate tabun-inhibited acetylcholinesterase Basic Clin Pharmacol Toxicol 20049581 6 doi 10.1111/j.1742-7843.2004.950207.x15379785Open DOISearch in Google Scholar

114Čalić M, Bosak A, Kuca K, Kovarik Z. Interactions of butane, but-2-ene or xylene-like linked bispyridinium paraaldoximes with native and tabun-inhibited human cholinesterases. Chem Biol Interact 2008;175:305–8. doi: 10.1016/j.cbi.2008.04.010 Čalić M Bosak A Kuca K Kovarik Z Interactions of butane, but-2-ene or xylene-like linked bispyridinium paraaldoximes with native and tabun-inhibited human cholinesterases Chem Biol Interact 2008175305 8 doi 10.1016/j.cbi.2008.04.01018501885Open DOISearch in Google Scholar

115Artursson E, Akfur C, Hörnberg A, Worek F, Ekström F. Reactivation of tabun-hAChE investigated by structurally analogous oximes and mutagenesis. Toxicology 2009;265:108–14. doi: 10.1016/j.tox.2009.09.002 Artursson E Akfur C HörnbergA Worek F Ekström F Reactivation of tabun-hAChE investigated by structurally analogous oximes and mutagenesis Toxicology 2009265108 14 doi 10.1016/j.tox.2009.09.00219761810Open DOISearch in Google Scholar

116Kovarik Z, Čalić M, Šinko G, Bosak A. Structure-activity approach in the reactivation of tabun-phosphorylated human acetylcholinesterase with bispyridinium para-aldoximes. Arh Hig Rada Toksikol 2007;58:201–9. doi: 10.2478/v10004-007-0013-7 Kovarik Z Čalić M Šinko G Bosak A Structure-activity approach in the reactivation of tabun-phosphorylated human acetylcholinesterase with bispyridinium para-aldoximes Arh Hig Rada Toksikol 200758201 9 doi 10.2478/v10004-007-0013-717562604Open DOISearch in Google Scholar

117Berend S, Katalinić M, Lucić Vrdoljak A, Kovarik Z, Kuca K, Radić B. In vivo experimental approach to treatment against tabun poisoning. J Enzyme Inhib Med Chem 2010;25:531–6. doi: 10.3109/14756360903357593 Berend S Katalinić M Lucić Vrdoljak A Kovarik Z Kuca K Radić B. In vivo experimental approach to treatment against tabun poisoning J Enzyme Inhib Med Chem 201025531 6 doi 10.3109/1475636090335759320235800Open DOISearch in Google Scholar

118Kovarik Z, Lucić Vrdoljak A, Berend S, Katalinić M, Kuča K, Musilek K, Radić B. Evaluation of oxime K203 as antidote in tabun poisoning. Arh Hig Rada Toksikol 2009;60:19–26. doi: 10.2478/10004-1254-60-2009-1890 Kovarik Z Lucić Vrdoljak A Berend S Katalinić M Kuča K Musilek K Radić B Evaluation of oxime K203 as antidote in tabun poisoning Arh Hig Rada Toksikol 20096019 26 doi 10.2478/10004-1254-60-2009-189019329372Open DOISearch in Google Scholar

119Elsinghorst PW, Worek F, Thiermann H, Wille T. Drug development for the management of organophosphorus poisoning. Expert Opin Drug Discov 2013;8:1467–77. doi: 10.1517/17460441.2013.847920 Elsinghorst PW Worek F Thiermann H Wille T Drug development for the management of organophosphorus poisoning Expert Opin Drug Discov 201381467 77 doi 10.1517/17460441.2013.84792024125474Open DOISearch in Google Scholar

120Seeger T, Eichhorn M, Lindner M, Niessen KV, Tattersall JEH, Timperley CM, Bird M, Green AC, Thiermann H, Worek F. Restoration of soman-blocked neuromuscular transmission in human and rat muscle by the bispyridinium non-oxime MB327 in vitro. Toxicology 2012:294:80–4. doi: 10.1016/j.tox.2012.02.002 Seeger T Eichhorn M Lindner M Niessen KV Tattersall JEH Timperley CM Bird M Green AC Thiermann H Worek F Restoration of soman-blocked neuromuscular transmission in human and rat muscle by the bispyridinium non-oxime MB327 in vitro Toxicology 201229480 4 doi 10.1016/j.tox.2012.02.00222349640Open DOISearch in Google Scholar

121Turner SR, Chad JE, Price M, Timperley CM, Bird M, Green AC, Tattersall JEH. Protection against nerve agent poisoning by a noncompetitive nicotinic antagonist. Toxicol Lett 2011;206:105–11. doi: 10.1016/j.toxlet.2011.05.1035 Turner SR Chad JE Price M Timperley CM Bird M Green AC Tattersall JEH Protection against nerve agent poisoning by a noncompetitive nicotinic antagonist Toxicol Lett 2011206105 11 doi 10.1016/j.toxlet.2011.05.103521641979Open DOISearch in Google Scholar

122Price ME, Whitmore CL, Tattersall JEH, Green AC, Rice H. Efficacy of the antinicotinic compound MB327 against soman poisoning - Importance of experimental end point. Toxicol Lett 2018;293:167–71. doi: 10.1016/j.toxlet.2017.11.006 Price ME Whitmore CL Tattersall JEH Green AC Rice H Efficacy of the antinicotinic compound MB327 against soman poisoning - Importance of experimental end point Toxicol Lett 2018293167 71 doi 10.1016/j.toxlet.2017.11.00629127032Open DOISearch in Google Scholar

123Katz FS, Pecic S, Tran TH, Trakht I, Schneider L, Zhu Z, Ton-That L, Luzac M, Zlatanic V, Damera S, Macdonald J, Landry DW, Tong L, Stojanovic MN. Discovery of new classes of compounds that reactivate acetylcholinesterase inhibited by organophosphates. Chembiochem 2015;16:2205–15. doi: 10.1002/cbic.201500348 Katz FS Pecic S Tran TH Trakht I Schneider L Zhu Z Ton-That L Luzac M Zlatanic V Damera S Macdonald J Landry DW Tong L Stojanovic MN Discovery of new classes of compounds that reactivate acetylcholinesterase inhibited by organophosphates Chembiochem 2015162205 15 doi 10.1002/cbic.201500348466417826350723Open DOISearch in Google Scholar

124de Koning MC, Horn G, Worek F, van Grol M. Discovery of a potent non-oxime reactivator of nerve agent inhibited human acetylcholinesterase. Eur J Med Chem 2018;157:151–60. doi: 10.1016/j.ejmech.2018.08.016 de Koning MC Horn G Worek F van Grol M Discovery of a potent non-oxime reactivator of nerve agent inhibited human acetylcholinesterase Eur J Med Chem 2018157151 60 doi 10.1016/j.ejmech.2018.08.01630096649Open DOISearch in Google Scholar

125Horn G, de Koning MC, van Grol M, Thiermann H, Worek F. Interactions between acetylcholinesterase, toxic organophosphorus compounds and a short series of structurally related non-oxime reactivators: Analysis of reactivation and inhibition kinetics in vitro. Toxicol Lett 2018;299:218–25. doi: 10.1016/j.toxlet.2018.10.004 Horn G de Koning MC van Grol M Thiermann H Worek F Interactions between acetylcholinesterase, toxic organophosphorus compounds and a short series of structurally related non-oxime reactivators: Analysis of reactivation and inhibition kinetics in vitro Toxicol Lett 2018299218 25 doi 10.1016/j.toxlet.2018.10.004Open DOISearch in Google Scholar

126McDonough JH Jr, Shih TM. Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci Biobehav Rev 1997;21:559–79. doi: 10.1016/s0149-7634(96)00050-4 McDonough JH Jr Shih TM Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology Neurosci Biobehav Rev 199721559 79 doi 10.1016/s0149-7634(96)00050-4Open DOISearch in Google Scholar

127Rump S. Convulsions in organophosphate intoxications: their mechanism and treatment. In: Sohns T, Voicu A, Szinicz L, Finke E-J, Mircioiu C, Lundy P, Brain KR, Kempf H, editors. NBC risks current capabilities and future perspectives for protection. NATO science series (Series 1: disarmament technologies). Vol 25. Dordrecht: Springer; 1999. p. 189–95. Rump S Convulsions in organophosphate intoxications: their mechanism and treatment In Sohns T Voicu A Szinicz L Finke E-J Mircioiu C Lundy P Brain KR Kempf H editors NBC risks current capabilities and future perspectives for protection. NATO science series (Series 1: disarmament technologies) Vol 25 Dordrecht Springer 1999 p 189 9510.1007/978-94-011-4641-8_15Search in Google Scholar

128Guignet M, Lein PJ. Neuroinflammation in organophosphate-induced neurotoxicity. In: Aschner M, Costa LG, editors. Advances in neurotoxicology. Vol 3. Massachusetts: Academic Press; 2019. p. 35–79. Guignet M Lein PJ Neuroinflammation in organophosphate-induced neurotoxicity In Aschner M Costa LG editors Advances in neurotoxicology Vol 3 Massachusetts Academic Press 2019 p 35 7910.1016/bs.ant.2018.10.003Search in Google Scholar

129Chen Z, Duan RS, Quezada HC, Mix E, Nennesmo I, Adem A, Winblad B, Zhu J. Increased microglial activation and astrogliosis after intranasal administration of kainic acid in C57BL/6 mice. J Neurobiol 2005;62:207–18. doi: 10.1002/neu.20099 Chen Z Duan RS Quezada HC Mix E Nennesmo I Adem A Winblad B Zhu J Increased microglial activation and astrogliosis after intranasal administration of kainic acid in C57BL/6 mice J Neurobiol 200562207 18 doi 10.1002/neu.2009915459893Open DOISearch in Google Scholar

130Banks CN, Lein PJ. A review of experimental evidence linking neurotoxic organophosphorus compounds and inflammation. Neurotoxicology 2012;33:575–84. doi: 10.1016/j.neuro.2012.02.002 Banks CN Lein PJ A review of experimental evidence linking neurotoxic organophosphorus compounds and inflammation Neurotoxicology 201233575 84 doi 10.1016/j.neuro.2012.02.002335851922342984Open DOISearch in Google Scholar

131Turtzo LC, Lescher J, Janes L, Dean DD, Budde MD, Frank JA. Macrophagic and microglial responses after focal traumatic brain injury in the female rat. J Neuroinflammation 2014;11:82. doi: 10.1186/1742-2094-11-82 Turtzo LC Lescher J Janes L Dean DD Budde MD Frank JA Macrophagic and microglial responses after focal traumatic brain injury in the female rat J Neuroinflammation 20141182 doi 10.1186/1742-2094-11-82402236624761998Open DOISearch in Google Scholar

132Becher B, Spath S, Goverman J. Cytokine networks in neuroinflammation. Nat Rev Immunol 2017;17:49–59. doi: 10.1038/nri.2016.123 Becher B Spath S Goverman J Cytokine networks in neuroinflammation Nat Rev Immunol 20171749 59 doi 10.1038/nri.2016.12327916979Open DOISearch in Google Scholar

133Marrs TC. Diazepam in the treatment of organophosphorus ester pesticide poisoning. Toxicol Rev 2003;22:75–81. doi: 10.2165/00139709-200322020-00002 Marrs TC Diazepam in the treatment of organophosphorus ester pesticide poisoning Toxicol Rev 20032275 81 doi 10.2165/00139709-200322020-0000215071817Open DOISearch in Google Scholar

134Tattersall J. Seizure activity post organophosphate exposure. Front Biosci (Landmark Ed) 2009;14:3688–711. doi: 10.2741/3481 Tattersall J Seizure activity post organophosphate exposure Front Biosci (Landmark Ed) 2009143688 711 doi 10.2741/348119273303Open DOISearch in Google Scholar

135Timperley CM, Abdollahi M, Al-Amri AS, Baulig A, Benachour D, Borrett V, Cariño FA, Geist M, Gonzalez D, Kane W, Kovarik Z, Martínez-Álvarez R, Fusaro Mourão NM, Neffe S, Raza SK, Rubaylo V, Suárez AG, Takeuchi K, Tang C, Trifirò F, van Straten FM, Vanninen PS, Vučinić S, Zaitsev V, Zafar-Uz-Zaman M, Zina MS, Holen S, Forman JE, Alwan WS, Suri V. Advice on assistance and protection from the Scientific Advisory Board of the Organisation for the Prohibition of Chemical Weapons: Part 2. On preventing and treating health effects from acute, prolonged, and repeated nerve agent exposure, and the identification of medical countermeasures able to reduce or eliminate the longer term health effects of nerve agents. Toxicology 2019;413:13–23. doi: 10.1016/j.tox.2018.11.009 Timperley CM Abdollahi M Al-Amri AS Baulig A Benachour D Borrett V Cariño FA Geist M Gonzalez D Kane W Kovarik Z Martínez-Álvarez R Fusaro Mourão NM Neffe S Raza SK Rubaylo V Suárez AG Takeuchi K Tang C Trifirò F van Straten FM Vanninen PS Vučinić S Zaitsev V Zafar-Uz-Zaman M Zina MS Holen S Forman JE Alwan WS Suri V Advice on assistance and protection from the Scientific Advisory Board of the Organisation for the Prohibition of Chemical Weapons: Part 2. On preventing and treating health effects from acute, prolonged, and repeated nerve agent exposure, and the identification of medical countermeasures able to reduce or eliminate the longer term health effects of nerve agents Toxicology 201941313 23 doi 10.1016/j.tox.2018.11.009Open DOISearch in Google Scholar

136Aroniadou-Anderjaska V, Apland JP, Figueiredo TH, De Araujo Furtado M, Braga MF. Acetylcholinesterase inhibitors (nerve agents) as weapons of mass destruction: History, mechanisms of action, and medical countermeasures. Neuropharmacology 2020;181:108298. doi: 10.1016/j. neuropharm.2020.108298 Aroniadou-Anderjaska V Apland JP Figueiredo TH De Araujo Furtado M Braga MF Acetylcholinesterase inhibitors (nerve agents) as weapons of mass destruction: History, mechanisms of action, and medical countermeasures Neuropharmacology 2020181108298 doi 10.1016/j.neuropharm.2020.108298Open DOISearch in Google Scholar

137North Atlantic Treaty Organization (NATO). Handbook on the medical aspects of NBC defensive operations [displayed 22 November 2020]. Available at https://fas.org/nuke/guide/usa/doctrine/dod/fm8-9/3ch2.htm North Atlantic Treaty Organization (NATO) Handbook on the medical aspects of NBC defensive operations [displayed 22 November 2020]. Available at https://fas.org/nuke/guide/usa/doctrine/dod/fm8-9/3ch2.htmSearch in Google Scholar

138Myhrer T, Aas P. Pretreatment and prophylaxis against nerve agent poisoning: Are undesirable behavioral side effects unavoidable? Neurosci Biobehav Rev 2016;71:657–70. doi: 10.1016/j.neubiorev.2016.10.017 Myhrer T Aas P Pretreatment and prophylaxis against nerve agent poisoning: Are undesirable behavioral side effects unavoidable? Neurosci Biobehav Rev 201671657 70 doi 10.1016/j.neubiorev.2016.10.017Open DOISearch in Google Scholar

139Layish I, Krivoy A, Rotman E, Finkelstein A, Tashma Z, Yehezkelli Y. Pharmacologic prophylaxis against nerve agent poisoning. Isr Med Assoc J 2005;7:182–7. PMID: 15792266 Layish I Krivoy A Rotman E Finkelstein A Tashma Z Yehezkelli Y. Pharmacologic prophylaxis against nerve agent poisoning Isr Med Assoc J 20057182 7 PMID: 15792266Search in Google Scholar

140Bajgar J, Fusek J, Kassa J, Kuca K, Jun D. Pharmacological prophylaxis against nerve agent poisoning: experimental studies and practical implications. In: Gupta RC, editor. Handbook of toxicology of chemical warfare agents. 2^nd ed. Cambridge, MA: Academic Press; 2015. p. 979–87. doi: 10.1016/B978-0-12-800159-2.00066-X Bajgar J Fusek J Kassa J Kuca K Jun D Pharmacological prophylaxis against nerve agent poisoning: experimental studies and practical implications In Gupta RC editor Handbook of toxicology of chemical warfare agents. 2^nd ed Cambridge, MA Academic Press 2015 p 979 87 doi 10.1016/B978-0-12-800159-2.00066-XOpen DOISearch in Google Scholar

141Bajgar J, Fusek J, Kassa J, Kuca K, Jun D. Chemical aspects of pharmacological prophylaxis against nerve agent poisoning. Curr Med Chem 2009;16:2977–86. doi: 10.2174/092986709788803088 Bajgar J Fusek J Kassa J Kuca K Jun D Chemical aspects of pharmacological prophylaxis against nerve agent poisoning Curr Med Chem 2009162977 86 doi 10.2174/092986709788803088Open DOISearch in Google Scholar

142Masson P. Evolution of and perspectives on therapeutic approaches to nerve agent poisoning. Toxicol Lett 2011;206:5–13. doi: 10.1016/j.toxlet.2011.04.006 Masson P Evolution of and perspectives on therapeutic approaches to nerve agent poisoning Toxicol Lett 20112065 13 doi 10.1016/j.toxlet.2011.04.006Open DOISearch in Google Scholar

143Lenz DE, Yeung D, Smith JR, Sweeney RE, Lumley LA, Cerasoli DM. Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review. Toxicology 2007;233:31–9. doi: 10.1016/j.tox.2006.11.066 Lenz DE Yeung D Smith JR Sweeney RE Lumley LA Cerasoli DM Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review Toxicology 200723331 9 doi 10.1016/j.tox.2006.11.066Open DOISearch in Google Scholar

144Nachon F, Brazzolotto X, Trovaslet M, Masson P. Progress in the development of enzyme-based nerve agent bioscavengers. Chem Biol Interact 2013;206:536–44. doi: 10.1016/j.cbi.2013.06.012 Nachon F Brazzolotto X Trovaslet M Masson P Progress in the development of enzyme-based nerve agent bioscavengers Chem Biol Interact 2013206536 44 doi 10.1016/j.cbi.2013.06.012Open DOISearch in Google Scholar

145Eckert S, Eyer P, Mückter H, Worek F. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds. Biochem Pharmacol 2006;72:344–57. doi: 10.1016/j.bcp.2006.04.015 Eckert S Eyer P Mückter H Worek F Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds Biochem Pharmacol 200672344 57 doi 10.1016/j.bcp.2006.04.015Open DOISearch in Google Scholar

146Gordon JJ, Leadbeater L, Maidment MP. The protection of animals against organophosphate poisoning by pretreatment with a carbamate. Toxicol Appl Pharmacol 1978;43:207–16. doi: 10.1016/s0041-008x(78)80045-3 Gordon JJ Leadbeater L Maidment MP The protection of animals against organophosphate poisoning by pretreatment with a carbamate Toxicol Appl Pharmacol 197843207 16 doi 10.1016/s0041-008x(78)80045-3Open DOISearch in Google Scholar

147Keeler JR, Hurst CG, Dunn MA. Pyridostigmine used as a nerve agent pretreatment under wartime conditions. JAMA 1991;266:693–5. doi: 10.1001/jama.1991.03470050093029 Keeler JR Hurst CG Dunn MA Pyridostigmine used as a nerve agent pretreatment under wartime conditions JAMA 1991266693 5 doi 10.1001/jama.1991.03470050093029Open DOISearch in Google Scholar

148Kassa J. Therapeutic and neuroprotective efficacy of pharmacological pretreatment and antidotal treatment of acute tabun or soman poisoning with the emphasis on pretreatment drug PANPAL. Arh Hig Rada Toksikol 2006;57:427–34. Kassa J Therapeutic and neuroprotective efficacy of pharmacological pretreatment and antidotal treatment of acute tabun or soman poisoning with the emphasis on pretreatment drug PANPAL Arh Hig Rada Toksikol 200657427 34Search in Google Scholar

149Golomb BA. Acetylcholinesterase inhibitors and Gulf War illnesses. Proc Natl Acad Sci U S A 2008;105:4295–300. doi: 10.1073/pnas.0711986105 Golomb BA Acetylcholinesterase inhibitors and Gulf War illnesses Proc Natl Acad Sci U S A 20081054295 300 doi 10.1073/pnas.0711986105239374118332428Open DOISearch in Google Scholar

150Leader H, Wolfe AD, Chiang PK, Gordon RK. Pyridophens: binary pyridostigmine-aprophen prodrugs with differential inhibition of acetylcholinesterase, butyrylcholinesterase, and muscarinic receptors. J Med Chem 2002;45:902–10. doi: 10.1021/jm010196t Leader H Wolfe AD Chiang PK Gordon RK Pyridophens: binary pyridostigmine-aprophen prodrugs with differential inhibition of acetylcholinesterase, butyrylcholinesterase, and muscarinic receptors J Med Chem 200245902 10 doi 10.1021/jm010196t11831902Open DOISearch in Google Scholar

151Philippens IH, Joosen MJ, Vanwersch RA. Stress adversely affects efficacy of physostigmine-scopolamine pretreatment against soman in guinea pigs. Pharmacol Biochem Behav 2005;82:125–32. doi: 10.1016/j.pbb.2005.07.018 Philippens IH Joosen MJ Vanwersch RA Stress adversely affects efficacy of physostigmine-scopolamine pretreatment against soman in guinea pigs Pharmacol Biochem Behav 200582125 32 doi 10.1016/j.pbb.2005.07.01816126267Open DOISearch in Google Scholar

152Aracava Y, Pereira EF, Akkerman M, Adler M, Albuquerque EX. Effectiveness of donepezil, rivastigmine, and (+/-) huperzine A in counteracting the acute toxicity of organophosphorus nerve agents: comparison with galantamine. J Pharmacol Exp Ther 2009;331:1014–24. doi: 10.1124/jpet.109.160028 Aracava Y Pereira EF Akkerman M Adler M Albuquerque EX Effectiveness of donepezil, rivastigmine, and (+/-) huperzine A in counteracting the acute toxicity of organophosphorus nerve agents: comparison with galantamine J Pharmacol Exp Ther 20093311014 24 doi 10.1124/jpet.109.160028278471319741148Open DOISearch in Google Scholar

153Pereira EF, Aracava Y, Alkondon M, Akkerman M, Merchenthaler I, Albuquerque EX. Molecular and cellular actions of galantamine: clinical implications for treatment of organophosphorus poisoning. J Mol Neurosci 2010;40:196–203. doi: 10.1007/s12031-009-9234-3 Pereira EF Aracava Y Alkondon M Akkerman M Merchenthaler I Albuquerque EX Molecular and cellular actions of galantamine: clinical implications for treatment of organophosphorus poisoning J Mol Neurosci 201040196 203 doi 10.1007/s12031-009-9234-319690988Open DOISearch in Google Scholar

154Alexandrova EA, Aracava Y, Pereira EF, Albuquerque EX. Pretreatment of Guinea pigs with galantamine prevents immediate and delayed effects of soman on inhibitory synaptic transmission in the hippocampus. J Pharmacol Exp Ther 2010;334:1051–8. doi: 10.1124/jpet.110.167700 Alexandrova EA Aracava Y Pereira EF Albuquerque EX Pretreatment of Guinea pigs with galantamine prevents immediate and delayed effects of soman on inhibitory synaptic transmission in the hippocampus J Pharmacol Exp Ther 20103341051 8 doi 10.1124/jpet.110.167700293966720554906Open DOISearch in Google Scholar

155Lucić Vrdoljak A, Čalić M, Radić B, Berend S, Jun D, Kuča K, Kovarik Z. Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning. Toxicology 2006;228:41–50. doi: 10.1016/j.tox.2006.08.012 Lucić Vrdoljak A Čalić M Radić B Berend S Jun D Kuča K Kovarik Z Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning Toxicology 200622841 50 doi 10.1016/j.tox.2006.08.01216982122Open DOISearch in Google Scholar

156Bajgar J. Complex view on poisoning with nerve agents and organophosphates. Acta Medica (Hradec Kralove) 2005;48:3–21. doi: 10.14712/18059694.2018.23 Bajgar J Complex view on poisoning with nerve agents and organophosphates Acta Medica (Hradec Kralove) 2005483 21 doi 10.14712/18059694.2018.23Open DOISearch in Google Scholar

157Maxwell DM, Brecht KM. Carboxylesterase: specificity and spontaneous reactivation of an endogenous scavenger for organophosphorus compounds. J Appl Toxicol 2001;21(Suppl 1):S103–7. doi: 10.1002/jat.833 Maxwell DM Brecht KM Carboxylesterase: specificity and spontaneous reactivation of an endogenous scavenger for organophosphorus compounds J Appl Toxicol 200121Suppl 1S103 7 doi 10.1002/jat.83311920929Open DOISearch in Google Scholar

158Sogorb MA, Vilanova E. Serum albumins and detoxication of anti-cholinesterase agents. Chem Biol Interact 2010;187:325–9. doi: 10.1016/j.cbi.2010.03.001 Sogorb MA Vilanova E Serum albumins and detoxication of anti-cholinesterase agents Chem Biol Interact 2010187325 9 doi 10.1016/j.cbi.2010.03.00120211614Open DOISearch in Google Scholar

159Lockridge O. Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses. Pharmacol Ther 2015;148:34–46. doi: 10.1016/j.pharmthera.2014.11.011 Lockridge O Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses Pharmacol Ther 201514834 46 doi 10.1016/j.pharmthera.2014.11.01125448037Open DOISearch in Google Scholar

160Doctor BP, Saxena A. Bioscavengers for the protection of humans against organophosphate toxicity. Chem Biol Interact 2005;157–158:167–71. doi: 10.1016/j.cbi.2005.10.024 Doctor BP Saxena A Bioscavengers for the protection of humans against organophosphate toxicity Chem Biol Interact 2005157–158167 71 doi 10.1016/j.cbi.2005.10.02416293236Open DOISearch in Google Scholar

161Kovarik Z, Maček Hrvat N. Efficient detoxification of nerve agents by oxime-assisted reactivation of acetylcholinesterase mutants. Neuropharmacology 2020;171:108111. doi: 10.1016/j.neuropharm.2020.108111 Kovarik Z Maček Hrvat N Efficient detoxification of nerve agents by oxime-assisted reactivation of acetylcholinesterase mutants Neuropharmacology 2020171108111 doi 10.1016/j.neuropharm.2020.10811132333945Open DOISearch in Google Scholar

162Liu Y, Li J, Lu Y. Enzyme therapeutics for systemic detoxification. Adv Drug Deliv Rev 2015;90:24–39. doi: 10.1016/j.addr.2015.05.005 Liu Y Li J Lu Y Enzyme therapeutics for systemic detoxification Adv Drug Deliv Rev 20159024 39 doi 10.1016/j.addr.2015.05.00525980935Open DOISearch in Google Scholar

163Zhang P, Jain P, Tsao C, Sinclair A, Sun F, Hung H-C, Bai T, Wu K, Jiang S. Butyrylcholinesterase nanocapsule as a long circulating bioscavenger with reduced immune response. J Control Release 2016;230:73–8. doi: 10.1016/j. jconrel.2016.04.008 Zhang P Jain P Tsao C Sinclair A Sun F Hung H-C Bai T Wu K Jiang S Butyrylcholinesterase nanocapsule as a long circulating bioscavenger with reduced immune response J Control Release 201623073 8 doi 10.1016/j.jconrel.2016.04.00827063423Open DOISearch in Google Scholar

164Ashani Y, Pistinner S. Estimation of the upper limit of human butyrylcholinesterase dose required for protection against organophosphates toxicity: a mathematically based toxicokinetic model. Toxicol Sci 2004;77:358–67. doi: 10.1093/toxsci/kfh012 Ashani Y Pistinner S Estimation of the upper limit of human butyrylcholinesterase dose required for protection against organophosphates toxicity: a mathematically based toxicokinetic model Toxicol Sci 200477358 67 doi 10.1093/toxsci/kfh01214600276Open DOISearch in Google Scholar

165Saxena A, Sun W, Fedorko JM, Koplovitz I, Doctor BP. Prophylaxis with human serum butyrylcholinesterase protects guinea pigs exposed to multiple lethal doses of soman or VX. Biochem Pharmacol 2011;81:164–9. doi: 10.1016/j. bcp.2010.09.007 Saxena A Sun W Fedorko JM Koplovitz I Doctor BP Prophylaxis with human serum butyrylcholinesterase protects guinea pigs exposed to multiple lethal doses of soman or VX Biochem Pharmacol 201181164 9 doi 10.1016/j.bcp.2010.09.00720846507Open DOISearch in Google Scholar

166Saxena A, Tipparaju P, Luo C, Doctor BP. Pilot-scale production of human serum butyrylcholinesterase suitable for use as a bioscavenger against nerve agent toxicity. Process Biochem 2010;45:1313–8. doi: 10.1016/j. procbio.2010.04.021 Saxena A Tipparaju P Luo C Doctor BP Pilot-scale production of human serum butyrylcholinesterase suitable for use as a bioscavenger against nerve agent toxicity Process Biochem 2010451313 8 doi 10.1016/j.procbio.2010.04.021Open DOISearch in Google Scholar

167Genovese RF, Sun W, Johnson CC, Ditargiani RC, Doctor BP, Saxena A. Safety of administration of human butyrylcholinesterase and its conjugates with soman or VX in rats. Basic Clin Pharmacol Toxicol 2010;106:428–34. doi: 10.1111/j.1742-7843.2009.00508.x Genovese RF Sun W Johnson CC Ditargiani RC Doctor BP Saxena A Safety of administration of human butyrylcholinesterase and its conjugates with soman or VX in rats Basic Clin Pharmacol Toxicol 2010106428 34 doi 10.1111/j.1742-7843.2009.00508.x20050840Open DOISearch in Google Scholar

168Čadež T, Kovarik Z. Advancements in recombinant technology for production of butyrylcholinesterase, a bioscavenger of nerve agents. Period Biol. 2020;121–122:55–63. doi: 10.18054/pb.v121i1-2.10867 Čadež T Kovarik Z Advancements in recombinant technology for production of butyrylcholinesterase, a bioscavenger of nerve agents Period Biol 2020121–12255 63 doi 10.18054/pb.v121i1-2.10867Open DOISearch in Google Scholar

169Nachon F, Nicolet Y, Viguiea N, Masson P, Fontecilla-Camps JC, Lockridge O. Engineering of a monomeric and lowglycosylated form of human butyrylcholinesterase: expression, purifcation, characterization and crystallization. Eur J Biochem 2002;269:630–7. doi: 10.1046/j.0014-2956.2001.02692.x Nachon F Nicolet Y Viguiea N Masson P Fontecilla-Camps JC Lockridge O Engineering of a monomeric and lowglycosylated form of human butyrylcholinesterase: expression, purifcation, characterization and crystallization Eur J Biochem 2002269630 7 doi 10.1046/j.0014-2956.2001.02692.x11856322Open DOISearch in Google Scholar

170Terekhov S, Smirnov I, Bobik T, Shamborant O, Zenkova M, Chernolovskaya E, Gladkikh D, Murashev A, Dyachenko I, Paliko V, Palikova Y, Knorre V, Belogurov A Jr, Ponomarenko N, Blackburn GM, Masson P, Gabibov A. A novel expression cassette delivers efficient production of exclusively tetrameric human butyrylcholinesterase with improved pharmacokinetics for protection against organophosphate poisoning. Biochimie 2015;118:51–9. doi: 10.1016/j.biochi.2015.07.028 Terekhov S Smirnov I Bobik T Shamborant O Zenkova M Chernolovskaya E Gladkikh D Murashev A Dyachenko I Paliko V Palikova Y Knorre V BelogurovA Jr Ponomarenko N Blackburn GM Masson P Gabibov A A novel expression cassette delivers efficient production of exclusively tetrameric human butyrylcholinesterase with improved pharmacokinetics for protection against organophosphate poisoning Biochimie 201511851 9 doi 10.1016/j.biochi.2015.07.02826239905Open DOISearch in Google Scholar

171Brazzolotto X, Wandhammer M, Ronco C, Trovaslet M, Jean L, Lockridge O, Renard PY, Nachon F. Human butyrylcholinesterase produced in insect cells: huprine-based affinity purification and crystal structure. FEBS J 2012;279:2905–16. doi: 10.1111/j.1742-4658.2012.08672.x Brazzolotto X Wandhammer M Ronco C Trovaslet M Jean L Lockridge O Renard PY Nachon F Human butyrylcholinesterase produced in insect cells: huprine-based affinity purification and crystal structure FEBS J 20122792905 16 doi 10.1111/j.1742-4658.2012.08672.x22726956Open DOISearch in Google Scholar

172Li S, Ip DT, Lin HQ, Liu JM, Miao YG, Ke LJ, Wan DC. High-level expression of functional recombinant human butyrylcholinesterase in silkworm larvae by Bac-to-Bac system. Chem Biol Interact 2010;187:101–5. doi: 10.1016/j. cbi.2010.03.055 Li S Ip DT Lin HQ Liu JM Miao YG Ke LJ Wan DC High-level expression of functional recombinant human butyrylcholinesterase in silkworm larvae by Bac-to-Bac system Chem Biol Interact 2010187101 5 doi 10.1016/j.cbi.2010.03.05520399761Open DOISearch in Google Scholar

173Geyer BC, Kannan L, Garnaud PE, Broomfield CA, Cadieux CL, Cherni I, Hodgins SM, Kasten SA, Kelley K, Kilbourne J, Oliver ZP, Otto TC, Puffenberger I, Reeves TE, Robbins N 2nd, Woods RR, Soreq H, Lenz DE, Cerasoli DM, Mor TS. Plant-derived human butyrylcholinesterase, but not an organophosphorous-compound hydrolyzing variant thereof, protects rodents against nerve agents. Proc Natl Acad Sci U S A 2010;107:20251–6. doi: 10.1073/pnas.1009021107 Geyer BC Kannan L Garnaud PE Broomfield CA Cadieux CL Cherni I Hodgins SM Kasten SA Kelley K Kilbourne J Oliver ZP Otto TC Puffenberger I Reeves TE Robbins N 2nd Woods RR Soreq H Lenz DE Cerasoli DM Mor TS Plant-derived human butyrylcholinesterase, but not an organophosphorous-compound hydrolyzing variant thereof, protects rodents against nerve agents Proc Natl Acad Sci U S A 201010720251 6 doi 10.1073/pnas.1009021107299664421059932Open DOISearch in Google Scholar

174Egelkrout E, Hayden CA, Wales M, Walker J, Novikov B, Grimsley J, Howard J. Production of the bioscavenger butyrylcholinesterase in maize. Mol Breeding 2017;37:136. doi: 10.1007/s11032-017-0731-8 Egelkrout E Hayden CA Wales M Walker J Novikov B Grimsley J Howard J Production of the bioscavenger butyrylcholinesterase in maize Mol Breeding 201737136 doi 10.1007/s11032-017-0731-8Open DOISearch in Google Scholar

175Corbin JM, Hashimoto BI, Karuppanan K, Kyser ZR, Wu L, Roberts BA, Noe AR, Rodriguez RL, McDonald KA, Nandi S. Semicontinuous bioreactor production of recombinant butyrylcholinesterase in transgenic rice cell suspension cultures. Front Plant Sci 2016;7:412. doi: 10.3389/fpls.2016.00412 Corbin JM Hashimoto BI Karuppanan K Kyser ZR Wu L Roberts BA Noe AR Rodriguez RL McDonald KA Nandi S Semicontinuous bioreactor production of recombinant butyrylcholinesterase in transgenic rice cell suspension cultures Front Plant Sci 20167412 doi 10.3389/fpls.2016.00412481450427066048Open DOISearch in Google Scholar

176Huang YJ, Huang Y, Baldassarre H, Wang B, Lazaris A, Leduc M, Bilodeau AS, Bellemare A, Côté M, Herskovits P, Touati M, Turcotte C, Valeanu L, Lemée N, Wilgus H, Bégin I, Bhatia B, Rao K, Neveu N, Brochu E, Pierson J, Hockley DK, Cerasoli DM, Lenz DE, Karatzas CN, Langermann S. Recombinant human butyrylcholinesterase from milk of transgenic animals to protect against organophosphate poisoning. Proc Natl Acad Sci U S A 2007;104:13603–8. doi: 10.1073/pnas.0702756104 Huang YJ Huang Y Baldassarre H Wang B Lazaris A Leduc M Bilodeau AS Bellemare A Côté M Herskovits P Touati M Turcotte C Valeanu L Lemée N Wilgus H Bégin I Bhatia B Rao K Neveu N Brochu E Pierson J Hockley DK Cerasoli DM Lenz DE Karatzas CN Langermann S Recombinant human butyrylcholinesterase from milk of transgenic animals to protect against organophosphate poisoning Proc Natl Acad Sci U S A 200710413603 8 doi 10.1073/pnas.0702756104193433917660298Open DOISearch in Google Scholar

177Terekhov SS, Smirnov IV, Stepanova AV, Bobik TV, Mokrushina YA, Ponomarenko NA, Belogurov AA Jr, Rubtsova MP, Kartseva OV, Gomzikova MO, Moskovtsev AA, Bukatin AS, Dubina MV, Kostryukova ES, Babenko VV, Vakhitova MT, Manolov AI, Malakhova MV, Kornienko MA, Tyakht AV, Vanyushkina AA, Ilina EN, Masson P, Gabibov AG, Altman S. Microfluidic droplet platform for ultrahigh-throughput single-cell screening of biodiversity. Proc Natl Acad Sci U S A 2017;114:2550–5. doi: 10.1073/pnas.1621226114 Terekhov SS Smirnov IV Stepanova AV Bobik TV Mokrushina YA Ponomarenko NA BelogurovAA Jr Rubtsova MP Kartseva OV Gomzikova MO Moskovtsev AA Bukatin AS Dubina MV Kostryukova ES Babenko VV Vakhitova MT Manolov AI Malakhova MV Kornienko MA Tyakht AV Vanyushkina AA Ilina EN Masson P Gabibov AG Altman S Microfluidic droplet platform for ultrahigh-throughput single-cell screening of biodiversity Proc Natl Acad Sci U S A 20171142550 5 doi 10.1073/pnas.1621226114534755428202731Open DOISearch in Google Scholar

178Brazzolotto X, Igert A, Guillon V, Santoni G, Nachon F. Bacterial expression of human butyrylcholinesterase as a tool for nerve agent bioscavengers development. Molecules 2017;22:1828. doi: 10.3390/molecules22111828 Brazzolotto X Igert A Guillon V Santoni G Nachon F Bacterial expression of human butyrylcholinesterase as a tool for nerve agent bioscavengers development Molecules 2017221828 doi 10.3390/molecules22111828615035429077024Open DOISearch in Google Scholar

179Gupta V, Cadieux LC, Mcmenamin D, Medina-Jaszek CA, Arif M, Ahonkhai O, Wielechowski E, Taheri M, Che Y, Goode T, Limberis MP, Li M, Cerasoli DM, Tretiakova AP, Wilson JM. Adeno-associated virus-mediated expression of human butyrylcholinesterase to treat organophosphate poisoning. PLoS One 2019;14(11):e0225188. doi: 10.1371/journal.pone.0225188 Gupta V Cadieux LC Mcmenamin D Medina-Jaszek CA Arif M Ahonkhai O Wielechowski E Taheri M Che Y Goode T Limberis MP Li M Cerasoli DM Tretiakova AP Wilson JM Adeno-associated virus-mediated expression of human butyrylcholinesterase to treat organophosphate poisoning PLoS One 20191411e0225188 doi 10.1371/journal.pone.0225188687693431765413Open DOISearch in Google Scholar

180Lockridge O, David E, Schopfer LM, Masson P, Brazzolotto X, Nachon F. Purification of recombinant human butyrylcholinesterase on Hupresin^® J Chromatogr B 2018;1102–1103:109–15. doi: 10.1016/j. jchromb.2018.10.026 Lockridge O David E Schopfer LM Masson P Brazzolotto X Nachon F Purification of recombinant human butyrylcholinesterase on Hupresin^® J Chromatogr B 20181102–1103109 15 doi 10.1016/j.jchromb.2018.10.026627510430384187Open DOISearch in Google Scholar

181Larson MA, Lockridge O, Hinrichs SH. Polyproline promotes tetramerization of recombinant human butyrylcholinesterase. Biochem J 2014;462:329–35. doi: 10.1042/BJ20140421 Larson MA Lockridge O Hinrichs SH Polyproline promotes tetramerization of recombinant human butyrylcholinesterase Biochem J 2014462329 35 doi 10.1042/BJ2014042124916051Open DOISearch in Google Scholar

182Rosenberg YJ, Saxena A, Sun W, Jiang X, Chilukuri N, Luo C, Doctor BP, Lee KD. Demonstration of in vivo stability and lack of immunogenicity of a polyethyleneglycolconjugated recombinant CHO-derived butyrylcholinesterase bioscavenger using a homologous macaque model. Chem Biol Interact 2010;187:279–86. doi: 10.1016/j.cbi.2010.02.042 Rosenberg YJ Saxena A Sun W Jiang X Chilukuri N Luo C Doctor BP Lee KD Demonstration of in vivo stability and lack of immunogenicity of a polyethyleneglycolconjugated recombinant CHO-derived butyrylcholinesterase bioscavenger using a homologous macaque model Chem Biol Interact 2010187279 86 doi 10.1016/j.cbi.2010.02.04220211615Open DOISearch in Google Scholar

183Terekhov SS, Smirnov IV, Shamborant OG, Bobik TV, Ilyushin DG, Murashev AN, Dyachenko IA, Palikov VA, Knorre VD, Belogurov AA, Ponomarenko NA, Kuzina ES, Genkin DD, Masson P, Gabibov AG. Chemical polysialylation and in vivo tetramerization improve pharmacokinetic characteristics of recombinant human butyrylcholinesterase-based bioscavengers. Acta Naturae 2015;7:136–41. doi: 10.32607/20758251-2015-7-4-136-141 Terekhov SS Smirnov IV Shamborant OG Bobik TV Ilyushin DG Murashev AN Dyachenko IA Palikov VA Knorre VD Belogurov AA Ponomarenko NA Kuzina ES Genkin DD Masson P Gabibov AG. Chemical polysialylation and in vivo tetramerization improve pharmacokinetic characteristics of recombinant human butyrylcholinesterase-based bioscavengers Acta Naturae 20157136 41 doi 10.32607/20758251-2015-7-4-136-141Open DOISearch in Google Scholar

184Huang YJ, Lundy PM, Lazaris A, Huang Y, Baldassarre H, Wang B, Turcotte C, Côté M, Bellemare A, Bilodeau AS, Brouillard S, Touati M, Herskovits P, Bégin I, Neveu N, Brochu E, Pierson J, Hockley DK, Cerasoli DM, Lenz DE, Wilgus H, Karatzas CN, Langermann S. Substantially improved pharmacokinetics of recombinant human butyrylcholinesterase by fusion to human serum albumin. BMC Biotechnol 2008;8:50. doi: 10.1186/1472-6750-8-50 Huang YJ Lundy PM Lazaris A Huang Y Baldassarre H Wang B Turcotte C Côté M Bellemare A Bilodeau AS Brouillard S Touati M Herskovits P Bégin I Neveu N Brochu E Pierson J Hockley DK Cerasoli DM Lenz DE Wilgus H Karatzas CN Langermann S Substantially improved pharmacokinetics of recombinant human butyrylcholinesterase by fusion to human serum albumin BMC Biotechnol 2008850 doi 10.1186/1472-6750-8-50241518018485214Open DOISearch in Google Scholar

185Ilyushin DG, Smirnov IV, Belogurov AA Jr, Dyachenko IA, Zharmukhamedova TIu, Novozhilova TI, Bychikhin EA, Serebryakova MV, Kharybin ON, Murashev AN, Anikienko KA, Nikolaev EN, Ponomarenko NA, Genkin DD, Blackburn GM, Masson P, Gabibov AG. Chemical polysialylation of human recombinant butyrylcholinesterase delivers a long-acting bioscavenger for nerve agents in vivo. Proc Natl Acad Sci U S A 2013;110:1243–8. doi: 10.1073/pnas.1211118110 Ilyushin DG Smirnov IV BelogurovAA Jr Dyachenko IA Zharmukhamedova TIu Novozhilova TI Bychikhin EA Serebryakova MV Kharybin ON Murashev AN Anikienko KA Nikolaev EN Ponomarenko NA Genkin DD Blackburn GM Masson P Gabibov AG Chemical polysialylation of human recombinant butyrylcholinesterase delivers a long-acting bioscavenger for nerve agents in vivo Proc Natl Acad Sci U S A 20131101243 8 doi 10.1073/pnas.1211118110355708223297221Open DOISearch in Google Scholar

186Atsmon J, Brill-Almon E, Nadri-Shay C, Chertkoff R, Alon S, Shaikevich D, Volokhov I, Haim KY, Bartfeld D, Shulman A, Ruderfer I, Ben-Moshe T, Shilovitzky O, Soreq H, Shaaltiel Y. Preclinical and first-in-human evaluation of PRX-105, a PEGylated, plant-derived, recombinant human acetylcholinesterase-R. Toxicol Appl Pharmacol 2015;287:202–9. doi: 10.1016/j.taap.2015.06.004 Atsmon J Brill-Almon E Nadri-Shay C Chertkoff R Alon S Shaikevich D Volokhov I Haim KY Bartfeld D Shulman A Ruderfer I Ben-Moshe T Shilovitzky O Soreq H Shaaltiel Y Preclinical and first-in-human evaluation of PRX-105, a PEGylated, plant-derived, recombinant human acetylcholinesterase-R Toxicol Appl Pharmacol 2015287202 9 doi 10.1016/j.taap.2015.06.00426051873Open DOISearch in Google Scholar

187Pascual L, Sayed SE, Martínez-Máñez R, Costero AM, Gil S, Gavina P, Sancenon F. Acetylcholinesterase-capped mesoporous silica nanoparticles that open in the presence of Maček Hrvat N, Kovarik Z. Counteracting poisoning with chemical warfare nerve agents Arh Hig Rada Toksikol 2020;71:266-284 diisopropylfluorophosphate (a sarin or soman simulant). Org Lett 2016;18:5548–51. doi: 10.1021/acs.orglett.6b02793 Pascual L Sayed SE Martínez-Máñez R Costero AM Gil S Gavina P Sancenon F Acetylcholinesterase-capped mesoporous silica nanoparticles that open in the presence of Maček Hrvat N, Kovarik Z Counteracting poisoning with chemical warfare nerve agents Arh Hig Rada Toksikol 202071266 284 diisopropylfluorophosphate (a sarin or soman simulant). Org Lett 2016;18:5548–51. doi 10.1021/acs.orglett.6b0279327754682Open DOISearch in Google Scholar

188Cohen O, Kronman C, Raveh L, Mazor O, Ordentlich A, Shafferman A. Comparison of polyethylene glycolconjugated recombinant human acetylcholinesterase and serum human butyrylcholinesterase as bioscavengers of organophosphate compounds. Mol Pharmacol 2006;70:1121–31. doi: 10.1124/mol.106.026179 Cohen O Kronman C Raveh L Mazor O Ordentlich A Shafferman A Comparison of polyethylene glycolconjugated recombinant human acetylcholinesterase and serum human butyrylcholinesterase as bioscavengers of organophosphate compounds Mol Pharmacol 2006701121 31 doi 10.1124/mol.106.02617916801396Open DOISearch in Google Scholar

189Masson P, Nachon F, Broomfield CA, Lenz DE, Verdier L, Schopfer LM, Lockridge O. A collaborative endeavor to design cholinesterase-based catalytic scavengers against toxic organophosphorus esters. Chem Biol Interact 2008;175:273–80. doi: 10.1016/j.cbi.2008.04.005 Masson P Nachon F Broomfield CA Lenz DE Verdier L Schopfer LM Lockridge O A collaborative endeavor to design cholinesterase-based catalytic scavengers against toxic organophosphorus esters Chem Biol Interact 2008175273 80 doi 10.1016/j.cbi.2008.04.00518508040Open DOISearch in Google Scholar

190Cochran R, Kalisiak J, Küçükkilinç, T, Radić Z, Garcia E, Zhang L, Ho KY, Amitai G, Kovarik Z, Fokin VV, Sharpless KB, Taylor P. Oxime-assisted acetylcholinesterase catalytic scavengers of organophosphates that resist aging. J Biol Chem 2011;286:29718–24. doi: 10.1074/jbc.M111.264739 Cochran R Kalisiak J Küçükkilinç T Radić Z Garcia E Zhang L Ho KY Amitai G Kovarik Z Fokin VV Sharpless KB Taylor P Oxime-assisted acetylcholinesterase catalytic scavengers of organophosphates that resist aging J Biol Chem 201128629718 24 doi 10.1074/jbc.M111.264739319101321730071Open DOISearch in Google Scholar

191Horn G, Wille T, Musilek K, Kuca K, Thiermann H, Worek F. Reactivation kinetics of 31 structurally different bispyridinium oximes with organophosphate-inhibited human butyrylcholinesterase. Arch Toxicol 2015;89:405–14. doi: 10.1007/s00204-014-1288-5 Horn G Wille T Musilek K Kuca K Thiermann H Worek F Reactivation kinetics of 31 structurally different bispyridinium oximes with organophosphate-inhibited human butyrylcholinesterase Arch Toxicol 201589405 14 doi 10.1007/s00204-014-1288-524912784Open DOISearch in Google Scholar

192Radić Z, Dale T, Kovarik Z, Berend S, Garcia E, Zhang L, Amitai G, Green C, Radić B, Duggan BM, Ajami D, Rebek J, Taylor P. Catalytic detoxification of nerve agent and pesticide organophosphates by butyrylcholinesterase assisted with non-pyridinium oximes. Biochem J 2013;450:231–42. doi: 10.1042/BJ20121612 Radić Z Dale T Kovarik Z Berend S Garcia E Zhang L Amitai G Green C Radić B Duggan BM Ajami D Rebek J Taylor P Catalytic detoxification of nerve agent and pesticide organophosphates by butyrylcholinesterase assisted with non-pyridinium oximes Biochem J 2013450231 42 doi 10.1042/BJ20121612477267323216060Open DOISearch in Google Scholar

193Sit RK, Fokin VV, Amitai G, Sharpless KB, Taylor P, Radić Z. Imidazole aldoximes effective in assisting butyrylcholinesterase catalysis of organophosphate detoxification. J Med Chem 2014;57:1378–89. doi: 10.1021/jm401650z Sit RK Fokin VV Amitai G Sharpless KB Taylor P Radić Z Imidazole aldoximes effective in assisting butyrylcholinesterase catalysis of organophosphate detoxification J Med Chem 2014571378 89 doi 10.1021/jm401650z416706824571195Open DOISearch in Google Scholar

194Bušić V, Katalinić M, Šinko G, Kovarik Z, Gašo-Sokač D. Pyridoxal oxime derivative potency to reactivate cholinesterases inhibited by organophosphorus compounds. Toxicol Lett 2016;262:114–22. doi: 10.1016/j. toxlet.2016.09.015 Bušić V Katalinić M Šinko G Kovarik Z Gašo-Sokač D Pyridoxal oxime derivative potency to reactivate cholinesterases inhibited by organophosphorus compounds Toxicol Lett 2016262114 22 doi 10.1016/j.toxlet.2016.09.01527693733Open DOISearch in Google Scholar

195Katalinić M, Maček Hrvat N, Baumann K, Morasi Piperčić S, Makarić S, Tomić S, Jović O, Hrenar T, Miličević A, Jelić D, Žunec S, Primožič I, Kovarik Z. A comprehensive evaluation of novel oximes in creation of butyrylcholinesterase-based nerve agent bioscavengers. Toxicol Appl Pharmacol 2016;310:195–204. doi: 10.1016/j.taap.2016.09.015 Katalinić M Maček Hrvat N Baumann K Morasi Piperčić S Makarić S Tomić S Jović O Hrenar T Miličević A Jelić D Žunec S Primožič I Kovarik Z A comprehensive evaluation of novel oximes in creation of butyrylcholinesterase-based nerve agent bioscavengers Toxicol Appl Pharmacol 2016310195 204 doi 10.1016/j.taap.2016.09.01527654152Open DOISearch in Google Scholar

196Katalinić M, Zandona A, Ramić A, Zorbaz T, Primožič I, Kovarik Z. New cinchona oximes evaluated as reactivators of acetylcholinesterase and butyrylcholinesterase inhibited by organophosphorus compounds. Molecules 2017;22(7):1234. doi: 10.3390/molecules22071234 Katalinić M Zandona A Ramić A Zorbaz T Primožič I Kovarik Z New cinchona oximes evaluated as reactivators of acetylcholinesterase and butyrylcholinesterase inhibited by organophosphorus compounds Molecules 20172271234 doi 10.3390/molecules22071234615198928737687Open DOISearch in Google Scholar

197Zorbaz T, Malinak D, Kuca K, Musilek K, Kovarik Z. Butyrylcholinesterase inhibited by nerve agents is efficiently reactivated with chlorinated pyridinium oximes. Chem Biol Interact 2019;307:16–20. doi: 10.1016/j.cbi.2019.04.020 Zorbaz T Malinak D Kuca K Musilek K Kovarik Z Butyrylcholinesterase inhibited by nerve agents is efficiently reactivated with chlorinated pyridinium oximes Chem Biol Interact 201930716 20 doi 10.1016/j.cbi.2019.04.02031004594Open DOISearch in Google Scholar

198Kovarik Z, Radić Z, Berman HA, Simeon-Rudolf V, Reiner E, Taylor P. Acetylcholinesterase active centre and gorge conformations analysed by combinatorial mutations and enantiomeric phosphonates. Biochem J 2003;373:33–40. doi: 10.1042/BJ20021862 Kovarik Z Radić Z Berman HA Simeon-Rudolf V Reiner E Taylor P Acetylcholinesterase active centre and gorge conformations analysed by combinatorial mutations and enantiomeric phosphonates Biochem J 200337333 40 doi 10.1042/BJ20021862Open DOISearch in Google Scholar

199Katalinić M, Šinko G, Maček Hrvat N, Zorbaz T, Bosak A, Kovarik Z. Oxime-assisted reactivation of tabun-inhibited acetylcholinesterase analysed by active site mutations. Toxicology 2018;406–407:104–13. doi: 10.1016/j. tox.2018.05.008 Katalinić M Šinko G Maček Hrvat N Zorbaz T Bosak A Kovarik Z Oxime-assisted reactivation of tabun-inhibited acetylcholinesterase analysed by active site mutations Toxicology 2018406–407104 13 doi 10.1016/j.tox.2018.05.008Open DOISearch in Google Scholar

200Kovarik Z, Radić Z, Berman HA, Taylor P. Mutation of acetylcholinesterase to enhance oxime-assisted catalytic turnover of methylphosphonates. Toxicology 2007;233:79–84. doi: 10.1016/j.tox.2006.08.032 Kovarik Z Radić Z Berman HA Taylor P Mutation of acetylcholinesterase to enhance oxime-assisted catalytic turnover of methylphosphonates Toxicology 200723379 84 doi 10.1016/j.tox.2006.08.032Open DOISearch in Google Scholar

201Taylor P, Kovarik Z, Reiner E, Radić Z. Acetylcholinesterase: converting a vulnerable target to a template for antidotes and detection of inhibitor exposure. Toxicology 2007;233:70–8. doi: 10.1016/j.tox.2006.11.061 Taylor P Kovarik Z Reiner E Radić Z Acetylcholinesterase: converting a vulnerable target to a template for antidotes and detection of inhibitor exposure Toxicology 200723370 8 doi 10.1016/j.tox.2006.11.061Open DOISearch in Google Scholar

202Katalinić M, Kovarik Z. Reactivation of tabun-inhibited acetylcholinesterase investigated by two oximes and mutagenesis. Croat Chem Acta 2012;85:209–12. doi: 10.5562/cca1815 Katalinić M Kovarik Z Reactivation of tabun-inhibited acetylcholinesterase investigated by two oximes and mutagenesis Croat Chem Acta 201285209 12 doi 10.5562/cca1815Open DOISearch in Google Scholar

203Kovarik Z, Maček Hrvat N, Žunec S, Katalinić M. Detoxification of tabun-exposed mice by an acetylcholinesterase mutant assisted with a novel pyridinium aldoxime. BiIol Serb 2019;41:4–8. doi: 10.5281/zenodo.3532038 Kovarik Z Maček Hrvat N Žunec S Katalinić M Detoxification of tabun-exposed mice by an acetylcholinesterase mutant assisted with a novel pyridinium aldoxime BiIol Serb 2019414 8 doi 10.5281/zenodo.3532038Open DOISearch in Google Scholar

204Mazor O, Cohen O, Kronman C, Raveh L, Stein D, Ordentlich A, Shafferman A. Aging-resistant organophosphate bioscavenger based on polyethylene glycol-conjugated F338A human acetylcholinesterase. Mol Pharmacol 2008;74:755–63. doi: 10.1124/mol.108.047449 Mazor O Cohen O Kronman C Raveh L Stein D Ordentlich A Shafferman A Aging-resistant organophosphate bioscavenger based on polyethylene glycol-conjugated F338A human acetylcholinesterase Mol Pharmacol 200874755 63 doi 10.1124/mol.108.047449Open DOISearch in Google Scholar

205Kronman C, Cohen O, Mazor O, Ordentlich A, Raveh L, Velan B, Shafferman A. Next generation OP-bioscavengers: a circulatory long-lived 4-PEG hypolysine mutant of F338AHuAChE with optimal pharmacokinetics and pseudo-catalytic characteristics. Chem Biol Interact 2010;187:253–8. doi: 10.1016/j.cbi.2009.12.004 Kronman C Cohen O Mazor O Ordentlich A Raveh L Velan B Shafferman A Next generation OP-bioscavengers: a circulatory long-lived 4-PEG hypolysine mutant of F338AHuAChE with optimal pharmacokinetics and pseudo-catalytic characteristics Chem Biol Interact 2010187253 8 doi 10.1016/j.cbi.2009.12.004Open DOISearch in Google Scholar

206Maček Hrvat N, Žunec S, Taylor P, Radić Z, Kovarik Z. HI-6 assisted catalytic scavenging of VX by acetylcholinesterase choline binding site mutants. Chem Biol Interact 2016;259:148–53. doi: 10.1016/j.cbi.2016.04.023 Maček Hrvat N Žunec S Taylor P Radić Z Kovarik Z HI-6 assisted catalytic scavenging of VX by acetylcholinesterase choline binding site mutants Chem Biol Interact 2016259148 53 doi 10.1016/j.cbi.2016.04.023Open DOISearch in Google Scholar

207Sweeney RE, Maxwell DM. A theoretical expression for the protection associated with stoichiometric and catalytic scavengers in a single compartment model of organophosphorus poisoning. Math Biosci 2003;181:133–43. doi: 10.1016/s0025-5564(02)00154-2 Sweeney RE Maxwell DM A theoretical expression for the protection associated with stoichiometric and catalytic scavengers in a single compartment model of organophosphorus poisoning Math Biosci 2003181133 43 doi 10.1016/s0025-5564(02)00154-2Open DOISearch in Google Scholar

208Ashani Y, Leader H, Aggarwal N, Silman I, Worek F, Sussman JL, Goldsmith M. In vitro evaluation of the catalytic activity of paraoxonases and phosphotriesterases predicts the enzyme circulatory levels required for in vivo protection against organophosphate intoxications. Chem Biol Interact 2016;259:252–6. doi: 10.1016/j.cbi.2016.04.039 Ashani Y Leader H Aggarwal N Silman I Worek F Sussman JL Goldsmith M. In vitro evaluation of the catalytic activity of paraoxonases and phosphotriesterases predicts the enzyme circulatory levels required for in vivo protection against organophosphate intoxications Chem Biol Interact 2016259252 6 doi 10.1016/j.cbi.2016.04.039509789127163850Open DOISearch in Google Scholar

209Rochu D, Chabrière E, Masson P. Human paraoxonase: a promising approach for pre-treatment and therapy of organophosphorus poisoning. Toxicology 2007;233:47–59. doi: 10.1016/j.tox.2006.08.037 Rochu D Chabrière E Masson P Human paraoxonase: a promising approach for pre-treatment and therapy of organophosphorus poisoning Toxicology 200723347 59 doi 10.1016/j.tox.2006.08.03717007987Open DOISearch in Google Scholar

210Bosak A, Bavec A, Konte T, Šinko G, Kovarik Z, Goličnik M. Interactions of paraoxonase-1 with pharmacologically relevant carbamates. Molecules 2020;25:1–15. doi: 10.3390/molecules25010211 Bosak A Bavec A Konte T Šinko G Kovarik Z Goličnik M Interactions of paraoxonase-1 with pharmacologically relevant carbamates Molecules 2020251 15 doi 10.3390/molecules25010211698307331947900Open DOISearch in Google Scholar

211Kirby SD, Norris J, Sweeney R, Bahnson BJ, Cerasoli DM. A rationally designed mutant of plasma platelet-activating factor acetylhydrolase hydrolyzes the organophosphorus nerve agent soman. Biochim Biophys Acta 2015;1854:1809–15. doi: 10.1016/j.bbapap.2015.09.001 Kirby SD Norris J Sweeney R Bahnson BJ Cerasoli DM A rationally designed mutant of plasma platelet-activating factor acetylhydrolase hydrolyzes the organophosphorus nerve agent soman Biochim Biophys Acta 201518541809 15 doi 10.1016/j.bbapap.2015.09.001463284026343853Open DOISearch in Google Scholar

212Hemmert AC, Otto TC, Wierdl M, Edwards CC, Fleming CD, MacDonald M, Cashman JR, Potter PM, Cerasoli DM, Redinbo MR. Human carboxylesterase 1 stereoselectively binds the nerve agent cyclosarin and spontaneously hydrolyzes the nerve agent sarin. Mol Pharmacol 2010;77:508–16. doi: 10.1124/mol.109.062356 Hemmert AC Otto TC Wierdl M Edwards CC Fleming CD MacDonald M Cashman JR Potter PM Cerasoli DM Redinbo MR Human carboxylesterase 1 stereoselectively binds the nerve agent cyclosarin and spontaneously hydrolyzes the nerve agent sarin Mol Pharmacol 201077508 16 doi 10.1124/mol.109.062356284594120051531Open DOISearch in Google Scholar

213Yeung DT, Smith JR, Sweeney RE, Lenz DE, Cerasoli DM. A gas chromatographic-mass spectrometric approach to examining stereoselective interaction of human plasma proteins with soman. J Anal Toxicol 2008;32:86–91. doi: 10.1093/jat/32.1.86 Yeung DT Smith JR Sweeney RE Lenz DE Cerasoli DM A gas chromatographic-mass spectrometric approach to examining stereoselective interaction of human plasma proteins with soman J Anal Toxicol 20083286 91 doi 10.1093/jat/32.1.8618269799Open DOISearch in Google Scholar

214Valiyaveettil M, Alamneh Y, Biggemann L, Soojhawon I, Doctor BP, Nambiar MP. Efficient hydrolysis of the chemical warfare nerve agent tabun by recombinant and purified human and rabbit serum paraoxonase 1. Biochem Biophys Res Commun 2010;403:97–102. doi: 10.1016/j.bbrc.2010.10.125 Valiyaveettil M Alamneh Y Biggemann L Soojhawon I Doctor BP Nambiar MP Efficient hydrolysis of the chemical warfare nerve agent tabun by recombinant and purified human and rabbit serum paraoxonase 1 Biochem Biophys Res Commun 201040397 102 doi 10.1016/j.bbrc.2010.10.12521040699Open DOISearch in Google Scholar

215Worek F, Seeger T, Goldsmith M, Ashani Y, Leader H, Sussman JS, Tawfik D, Thiermann H, Wille T. Efficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro. Arch Toxicol 2014;88:1257–66. doi: 10.1007/s00204-014-1204-z Worek F Seeger T Goldsmith M Ashani Y Leader H Sussman JS Tawfik D Thiermann H Wille T Efficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro Arch Toxicol 2014881257 66 doi 10.1007/s00204-014-1204-z24477626Open DOISearch in Google Scholar

216Masson P, Rochu D. Catalytic bioscavengers against toxic esters, an alternative approach for prophylaxis and treatments of poisonings. Acta Naturae 2009;1:68–79. PMCID: PMC3347506 Masson P Rochu D Catalytic bioscavengers against toxic esters, an alternative approach for prophylaxis and treatments of poisonings Acta Naturae 2009168 79 PMCID: PMC334750610.32607/20758251-2009-1-1-68-79Search in Google Scholar

217Bigley AN, Xu C, Henderson TJ, Harvey SP, Raushel FM. Enzymatic neutralization of the chemical warfare agent VX: evolution of phosphotriesterase for phosphorothiolate hydrolysis. J Am Chem Soc 2013;135:10426–32. doi: 10.1021/ja402832z Bigley AN Xu C Henderson TJ Harvey SP Raushel FM Enzymatic neutralization of the chemical warfare agent VX: evolution of phosphotriesterase for phosphorothiolate hydrolysis J Am Chem Soc 201313510426 32 doi 10.1021/ja402832z374722823789980Open DOISearch in Google Scholar

218Goldsmith M, Eckstein S, Ashani Y, Greisen P Jr, Leader H, Sussman JL, Aggarwal N, Ovchinnikov S, Tawfik DS, Baker D, Thiermann H, Worek F. Catalytic efficiencies of directly evolved phosphotriesterase variants with structurally different organophosphorus compounds in vitro. Arch Toxicol 2016;90:2711–24. doi: 10.1007/s00204-015-1626-2 Goldsmith M Eckstein S Ashani Y GreisenP Jr Leader H Sussman JL Aggarwal N Ovchinnikov S Tawfik DS Baker D Thiermann H Worek F Catalytic efficiencies of directly evolved phosphotriesterase variants with structurally different organophosphorus compounds in vitro Arch Toxicol 2016902711 24 doi 10.1007/s00204-015-1626-226612364Open DOISearch in Google Scholar

219Smirnov I, Belogurov A Jr, Friboulet A, Masson P, Gabibov A, Renard PY. Strategies for the selection of catalytic antibodies against organophosphorus nerve agents. Chem Biol Interact 2013;203:196–201. doi: 10.1016/j. cbi.2012.10.011 Smirnov I BelogurovA Jr Friboulet A Masson P Gabibov A Renard PY Strategies for the selection of catalytic antibodies against organophosphorus nerve agents Chem Biol Interact 2013203196 201 doi 10.1016/j.cbi.2012.10.01123123255Open DOISearch in Google Scholar

220Letort S, Balieu S, Erb W, Gouhier G, Estour F. Interactions of cyclodextrins and their derivatives with toxic organophosphorus compounds. Beilstein J Org Chem 2016;12:204–28. doi: 10.3762/bjoc.12.23 Letort S Balieu S Erb W Gouhier G Estour F Interactions of cyclodextrins and their derivatives with toxic organophosphorus compounds Beilstein J Org Chem 201612204 28 doi 10.3762/bjoc.12.23477850026977180Open DOISearch in Google Scholar

221Taylor PW, Lukey BJ, Clark CR, Lee RB, Roussel RR. Field verification of Test-mate ChE. Mil Med 2003;168:314–9. PMID: 12733677 Taylor PW Lukey BJ Clark CR Lee RB Roussel RR Field verification of Test-mate ChE Mil Med 2003168314 9 PMID: 1273367710.1093/milmed/168.4.314Search in Google Scholar

222Worek F, Baumann M, Pfeiffer B, Aurbek N, Balszuweit F, Thiermann H. Cholinesterase kit for field diagnosis of organophosphate exposure. CBRN Medical Defense International 2013 [displayed 13 November 2020]. Available at https://www.securetec.net/wp-content/uploads/2018/08/Challenge_ChE_check_mobile_Special_2013.pdf Worek F Baumann M Pfeiffer B Aurbek N Balszuweit F Thiermann H Cholinesterase kit for field diagnosis of organophosphate exposure CBRN Medical Defense International 2013 [displayed 13 November 2020]. Available at https://www.securetec.net/wp-content/uploads/2018/08/Challenge_ChE_check_mobile_Special_2013.pdfSearch in Google Scholar

223Moshiri M, Darchini-Maragheh E, Balali-Mood M. Advances in toxicology and medical treatment of chemical warfare nerve agents. Daru 2012;20(1):81. doi: 10.1186/2008-2231-20-81 Moshiri M Darchini-Maragheh E Balali-Mood M Advances in toxicology and medical treatment of chemical warfare nerve agents Daru 201220181 doi 10.1186/2008-2231-20-81355604123351280Open DOISearch in Google Scholar